GOPRO, INC., 10-K filed on 2/9/2024
Annual Report
v3.24.0.1
Cover - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Jan. 31, 2024
Jun. 30, 2023
Class of Stock [Line Items]      
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 77-0629474    
Entity Address, Address Line One 3025 Clearview Way    
Entity Address, City or Town San Mateo,    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94402    
Title of 12(b) Security Class A common stock, $0.0001 par value    
Trading Symbol GPRO    
Entity Registrant Name GOPRO, INC.    
City Area Code (650)    
Local Phone Number 332-7600    
Entity Central Index Key 0001500435    
Entity Filer Category Accelerated Filer    
Document Type 10-K    
Document Period End Date Dec. 31, 2023    
Document Transition Report false    
Entity File Number 001-36514    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Amendment Flag false    
Entity Emerging Growth Company false    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Shell Company false    
Security Exchange Name NASDAQ    
Entity Voluntary Filers No    
ICFR Auditor Attestation Flag true    
Document Annual Report true    
Entity Small Business false    
Entity Public Float     $ 522,125
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Document Financial Statement Error Correction [Flag] false    
Common Class A [Member]      
Class of Stock [Line Items]      
Entity Common Stock, Shares Outstanding   123,638,372  
Common Class B [Member]      
Class of Stock [Line Items]      
Entity Common Stock, Shares Outstanding   26,258,546  
v3.24.0.1
Audit Information - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Audit Information [Abstract]      
Auditor Name PricewaterhouseCoopers LLP    
Auditor Location San Jose, California    
Auditor Firm ID 238    
Revenue $ 1,005,459 $ 1,093,541 $ 1,161,084
v3.24.0.1
Condensed Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Jan. 01, 2022
Preferred Stock, par value (usd per share) $ 0.0001 $ 0.0001  
Preferred Stock, Shares Authorized (shares) 5,000,000 5,000,000  
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001  
Treasury Stock, Value $ 193,231,000 $ 153,231,000  
Common Stocks, Including Additional Paid in Capital 998,373,000 960,903,000 $ 78,200,000
Preferred Stock, Value, Outstanding $ 0 $ 0  
Treasury Stock, Common, Shares 26,608,000 16,677,000  
Cash and cash equivalents $ 222,708,000 $ 223,735,000  
Marketable securities 23,867,000 143,602,000  
Accounts receivable, net 91,452,000 77,008,000  
Inventory 106,266,000 127,131,000  
Prepaid expenses and other current assets 38,298,000 34,551,000  
Property and equipment, net 8,686,000 13,327,000  
Operating Lease, Right-of-Use Asset 18,729,000 21,819,000  
Goodwill 146,459,000 146,459,000  
Other long-term assets 311,486,000 289,293,000  
Accounts payable 102,612,000 91,648,000  
Accrued expenses and other current liabilities 110,049,000 118,877,000  
Short-term operating lease liabilities 10,520,000 9,553,000  
Deferred revenue 55,913,000 55,850,000  
Long-term taxes payable 11,199,000 9,536,000  
Long-term debt 92,615,000 141,017,000  
Long-term operating lease liabilities 25,527,000 33,446,000  
Other long-term liabilities 3,670,000 5,439,000 7,300,000
Accumulated deficit (249,296,000) (196,113,000) 47,100,000
Current assets:      
Cash and cash equivalents 222,708,000 223,735,000  
Marketable securities 23,867,000 143,602,000  
Accounts receivable, net 91,452,000 77,008,000  
Inventory 106,266,000 127,131,000  
Prepaid expenses and other current assets 38,298,000 34,551,000  
Total current assets 482,591,000 606,027,000  
Property and equipment, net 8,686,000 13,327,000  
Operating Lease, Right-of-Use Asset 18,729,000 21,819,000  
Goodwill 146,459,000 146,459,000  
Other long-term assets 311,486,000 289,293,000  
Total assets 967,951,000 1,076,925,000  
Current liabilities:      
Accounts payable 102,612,000 91,648,000  
Accrued expenses and other current liabilities 110,049,000 118,877,000  
Short-term operating lease liabilities 10,520,000 9,553,000  
Deferred revenue 55,913,000 55,850,000  
Total current liabilities 279,094,000 275,928,000  
Long-term taxes payable 11,199,000 9,536,000  
Long-term debt 92,615,000 141,017,000  
Long-term operating lease liabilities 25,527,000 33,446,000  
Other long-term liabilities 3,670,000 5,439,000 7,300,000
Total liabilities 412,105,000 465,366,000  
Commitments, contingencies and guarantees  
Stockholders’ equity:      
Preferred Stock, Value, Outstanding 0 0  
Common Stocks, Including Additional Paid in Capital 998,373,000 960,903,000 78,200,000
Treasury Stock, Value (193,231,000) (153,231,000)  
Accumulated deficit (249,296,000) (196,113,000) $ 47,100,000
Total stockholders’ equity 555,846,000 611,559,000  
Total liabilities and stockholders’ equity $ 967,951,000 $ 1,076,925,000  
Preferred Stock, par value (usd per share) $ 0.0001 $ 0.0001  
Preferred Stock, Shares Authorized (shares) 5,000,000 5,000,000  
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001  
Treasury Stock, Common, Shares 26,608,000 16,677,000  
Common Class A [Member]      
Common stock outstanding (shares) 123,638,000 128,629,000  
Common Stock, Shares Authorized (shares) 500,000,000 500,000,000  
Common Stock, Shares, Issued 123,638,000 128,629,000  
Stockholders’ equity:      
Common Stock, Shares Authorized (shares) 500,000,000 500,000,000  
Common Stock, Shares, Issued 123,638,000 128,629,000  
Common Class B [Member]      
Common stock outstanding (shares) 26,259,000 26,259,000  
Common Stock, Shares Authorized (shares) 150,000,000 150,000,000  
Common Stock, Shares, Issued 26,259,000 26,259,000  
Stockholders’ equity:      
Common Stock, Shares Authorized (shares) 150,000,000 150,000,000  
Common Stock, Shares, Issued 26,259,000 26,259,000  
v3.24.0.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Preferred Stock, par value (usd per share) $ 0.0001 $ 0.0001
Preferred Stock, Shares Authorized (shares) 5,000,000 5,000,000
Preferred Stock, Shares Issued (shares) 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Treasury Stock, Common, Shares 26,608,000 16,677,000
Common Class A [Member]    
Common Stock, Shares Authorized (shares) 500,000,000 500,000,000
Common Stock, Shares, Issued 123,638,000 128,629,000
Common stock outstanding (shares) 123,638,000 128,629,000
Common Class B [Member]    
Common Stock, Shares Authorized (shares) 150,000,000 150,000,000
Common Stock, Shares, Issued 26,259,000 26,259,000
Common stock outstanding (shares) 26,259,000 26,259,000
v3.24.0.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Revenue $ 1,005,459,000 $ 1,093,541,000 $ 1,161,084,000
Cost of revenue 681,886,000 686,713,000 683,979,000
Gross profit 323,573,000 406,828,000 477,105,000
Operating expenses:      
Research and development 165,688,000 139,885,000 141,494,000
Sales and marketing 169,578,000 166,967,000 156,694,000
General and administrative 63,770,000 61,021,000 65,701,000
Total operating expenses 399,036,000 367,873,000 363,889,000
Operating income (loss) (75,463,000) 38,955,000 113,216,000
Interest expense (4,699,000) (6,242,000) (22,940,000)
Other income (expense), net     (176,000)
Other income (expense), net 12,429,000 1,740,000  
Total other income (expense), net 7,730,000 (4,502,000) (23,116,000)
Income (loss) before income taxes (67,733,000) 34,453,000 90,100,000
Income tax expense (benefit) (14,550,000) 5,606,000 (281,071,000)
Net income (loss) $ (53,183,000) $ 28,847,000 $ 371,171,000
Earnings Per Share, Basic $ (0.35) $ 0.18 $ 2.41
Earnings Per Share, Diluted $ (0.35) $ 0.18 $ 2.27
Weighted Average Number of Shares Outstanding, Basic 153,348 156,181 154,274
Weighted Average Number of Shares Outstanding, Diluted 153,348 178,279 163,178
v3.24.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Operating activities:      
Net income (loss) $ (53,183) $ 28,847 $ 371,171
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization 6,160 8,570 10,962
Non-cash operating lease cost 3,090 5,501 4,240
Stock-based compensation 41,479 38,991 38,650
Deferred income taxes (17,891) 2,710 (273,541)
Non-cash restructuring charges 0 228 (99)
Gain (Loss) on Extinguishment of Debt 3,092 0 0
Amortization of Debt Discount (Premium) 0 0 14,208
Other (2,600) 1,022 2,243
Changes in operating assets and liabilities:      
Accounts receivable, net (14,478) 37,829 (8,142)
Inventory 20,865 (40,722) 11,505
Prepaid expenses and other assets (7,649) 7,922 (17,513)
Accounts payable and other liabilities (4,226) (97,112) 56,262
Deferred revenue (1,338) 11,961 19,207
Net Cash Provided by (Used in) Operating Activities (32,863) 5,747 229,153
Investing activities:      
Purchases of property and equipment, net (1,520) (3,447) (5,545)
Purchases of marketable securities (25,782) (165,590) (146,515)
Maturities of marketable securities 149,204 160,649 8,341
Net cash provided by (used in) investing activities 121,902 (8,388) (143,719)
Financing activities:      
Proceeds from issuance of common stock 3,876 4,760 7,490
Payment, Tax Withholding, Share-based Payment Arrangement (8,008) (13,410) (17,379)
Payments for Repurchase of Common Stock (40,000) (39,619) 0
Early Repayment of Senior Debt (46,250) 0 0
Repayments of Lines of Credit 0 (125,000) 0
Payments for Repurchase of Common Stock 40,000 39,619 0
Net cash used in financing activities (90,382) (173,269) (9,889)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 316 (1,442) (2,112)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (1,027) (177,352) 73,433
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 222,708 223,735 401,087
Interest Paid, Including Capitalized Interest, Operating and Investing Activities 1,976 4,258 6,127
Income Taxes Paid, Net (537) 2,100 810
Capital Expenditures Incurred but Not yet Paid $ 214 $ 215 $ 587
v3.24.0.1
Condensed Consolidated Statements Stockholders' Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Retained Earnings [Member]
Common Stock Including Additional Paid in Capital [Member]
Treasury Stock, Common
Stockholders' Equity Attributable to Parent $ 216,018 $ (650,516) $ 980,147 $ (113,613)
Shares, Outstanding     151,119  
Allocated share-based compensation expense     $ 38,651  
Payments for Repurchase of Common Stock 0      
Net income (loss) 371,171 371,171    
Common stock issued under employee benefit plans, net of shares withheld for tax 7,453   $ 7,453  
Common stock issued under employee benefit plans, net of shares withheld for tax (shares)     5,355  
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 17,379   $ (17,379)  
Stockholders' Equity Attributable to Parent 615,914 (279,345) $ 1,008,872 (113,613)
Shares, Outstanding     156,474  
Allocated share-based compensation expense     $ 38,991  
Payments for Repurchase of Common Stock 39,619      
Treasury Stock, Value, Acquired, Par Value Method (1)      
Stock Repurchased During Period, Value (39,618)      
Treasury Stock, Value, Acquired, Cost Method $ (39,618)      
Stock Repurchased During Period, Shares (5,967)      
Net income (loss) $ 28,847 28,847    
Common stock issued under employee benefit plans, net of shares withheld for tax 4,681   $ 4,681  
Common stock issued under employee benefit plans, net of shares withheld for tax (shares)     4,381  
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation $ 13,410   $ (13,410)  
Change in Accounting Principle, Accounting Standards Update, Adopted [true false] true      
Stockholders' Equity Attributable to Parent $ 611,559 (196,113) $ 960,903 (153,231)
Shares, Outstanding     154,888  
Allocated share-based compensation expense     $ 41,479  
Payments for Repurchase of Common Stock 40,000      
Treasury Stock, Value, Acquired, Par Value Method 0      
Stock Repurchased During Period, Value (40,000)      
Treasury Stock, Value, Acquired, Cost Method $ (40,000)      
Stock Repurchased During Period, Shares (9,931)      
Net income (loss) $ (53,183) (53,183)    
Common stock issued under employee benefit plans, net of shares withheld for tax 3,999   $ 3,999  
Common stock issued under employee benefit plans, net of shares withheld for tax (shares)     4,940  
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 8,008   $ (8,008)  
Stockholders' Equity Attributable to Parent $ 555,846 $ (249,296) $ 998,373 $ (193,231)
Shares, Outstanding     149,897  
v3.24.0.1
Summary of business and significant accounting policies
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Employee benefit plans
Stock-based compensation. Stock-based awards granted to qualified employees, non-employee directors and consultants are measured at fair value and recognized as an expense. The Company primarily issues restricted stock units and accounts for forfeitures as they occur. For service-based awards, stock-based compensation is recognized on a straight-line basis over the requisite service period. For performance and market-based awards which also require a service period, the Company uses graded vesting over the longer of the derived service period or when the performance or market condition is satisfied.
Cash, Cash Equivalents, and Marketable Securities
Cash equivalents and marketable securities. Cash equivalents consist of investments in money market funds with maturities of three months or less from the date of purchase. Marketable securities consist of U.S. treasury securities, commercial paper, government securities and corporate debt securities, and are classified as available-for-sale securities. The Company views these securities as available to support current operations and has classified all available-for-sale securities as current assets. Available-for-sale securities are carried at fair value with unrealized gains and losses, if any, included in stockholders’ equity. Unrealized gains and losses are charged against other income (expense), net, for declines in fair value below the cost of an individual investment that is deemed to be other than temporary. The Company has not identified any marketable securities as other-than-temporarily impaired for the periods presented. The cost of securities sold is based upon a specific identification method.
v3.24.0.1
Fair value measurements
 12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value measurements Fair value measurements
The Company’s assets that are measured at fair value on a recurring basis within the fair value hierarchy are summarized as follows:
December 31, 2023December 31, 2022
(in thousands)Level 1Level 2TotalLevel 1Level 2Total
Cash equivalents (1):
Money market funds$152,760 $— $152,760 $138,394 $— $138,394 
Total cash equivalents$152,760 $— $152,760 $138,394 $— $138,394 
Marketable securities:
U.S. treasury securities$— $7,962 $7,962 $— $14,716 $14,716 
Commercial paper— 7,942 7,942 — 87,436 87,436 
Corporate debt securities— 3,978 3,978 — 29,637 29,637 
Government securities— 3,985 3,985 — 11,813 11,813 
Total marketable securities$— $23,867 $23,867 $— $143,602 $143,602 
(1)    Included in cash and cash equivalents in the accompanying Consolidated Balance Sheets. Cash balances were $69.9 million and $85.3 million as of December 31, 2023 and 2022, respectively.
Cash equivalents are classified as Level 1 because the Company uses quoted market prices to determine their fair value. Marketable securities are classified as Level 2 because the Company uses alternative pricing sources and models utilizing market observable inputs to determine their fair value. The contractual maturities of available-for-sale marketable securities as of December 31, 2023 were all less than one year in duration. At December 31, 2023 and 2022, the Company had no financial assets or liabilities measured at fair value on a recurring basis that were classified as Level 3, which are valued based on inputs supported by little or no market activity.
At December 31, 2023 and 2022, the amortized cost of the Company’s cash equivalents and marketable securities approximated their fair value and there were no material realized or unrealized gains or losses, either individually or in the aggregate.
In November 2020, the Company issued $143.8 million principal amount of Convertible Senior Notes due 2025 (2025 Notes) (see Note 4 Financing arrangements). In November 2023, the Company repurchased $50.0 million in aggregate principal amount of the 2025 Notes. The estimated fair value of the 2025 Notes is based on quoted market prices of the Company’s instruments in markets that are not active and are classified as Level 2 within the fair value hierarchy. The Company estimated the fair value of the 2025 Notes by evaluating quoted market prices and calculating the upfront cash payment a market participant would require to assume these obligations. The calculated fair value of the 2025 Notes was $82.3 million and $130.1 million as of December 31, 2023 and 2022, respectively. The calculated fair value is highly correlated to the Company’s stock price and as a result, significant changes to the Company’s stock price will have a significant impact on the calculated fair value of the 2025 Notes.
For certain other financial assets and liabilities, including accounts receivable, accounts payable and other current assets and liabilities, the carrying amounts approximate their fair value primarily due to the relatively short maturity of these balances.
The Company also measures certain non-financial assets at fair value on a nonrecurring basis, primarily goodwill, intangible assets, and operating lease right-of-use assets, in connection with periodic evaluations for potential impairment.
v3.24.0.1
Financing Arrangements
 12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Financing Arrangements
4. Financing arrangements
2021 Credit Facility
In January 2021, the Company entered into a Credit Agreement which provides for a revolving credit facility (2021 Credit Facility) under which the Company may borrow up to an aggregate amount of $50.0 million. In March 2023, the Company amended the 2021 Credit Agreement (collectively, the 2021 Credit Agreement). The 2021 Credit Agreement will terminate and any outstanding borrowings become due and payable on the earlier of (i) January 2027 and (ii) unless the Company has cash in a specified deposit account in an amount equal to or greater than the amount required to repay the Company’s 1.25% convertible senior notes due November 2025, 91 days prior to the maturity date of such convertible notes.
The amount that may be borrowed under the 2021 Credit Agreement may be based on a customary borrowing base calculation if the Company’s Asset Coverage Ratio is at any time less than 1.50. The Asset Coverage Ratio is defined as the ratio of (i) the sum of (a) the Company’s cash and cash equivalents in the United States plus specified percentages of other qualified debt investments (Qualified Cash) plus (b) specified percentages of the net book values of the Company’s accounts receivable and certain inventory to (ii) $50.0 million.
Borrowed funds accrue interest at the greater of (i) a per annum rate equal to the base rate plus a margin of from 0.50% to 1.00% depending on the Company’s Asset Coverage Ratio or (ii) a per annum rate equal to the Secured Overnight Financing Rate plus a 10 basis point premium and a margin of from 1.50% to 2.00% depending on the Company’s Asset Coverage Ratio. The Company is required to pay a commitment fee on the unused portion of the 2021 Credit Facility of 0.25% per annum. Amounts owed under the 2021 Credit Agreement are guaranteed by certain of the Company’s United States subsidiaries and secured by a first priority security interest in substantially all of the assets of the Company and certain of its subsidiaries (other than intellectual property, which is subject to a negative pledge restricting grants of security interests to third parties).
The 2021 Credit Agreement contains customary representations, warranties, and affirmative and negative covenants. The negative covenants include restrictions on the incurrence of liens and indebtedness, certain investments, dividends, stock repurchases, and other matters, all subject to certain exceptions. In addition, the Company is required to maintain Liquidity (the sum of unused availability under the credit facility and the Company’s Qualified Cash) of at least $55.0 million (of which at least $40.0 million shall be attributable to Qualified Cash), or, if the borrowing base is then in effect, minimum unused availability under the credit facility of at least $10.0 million. The 2021 Credit Agreement also includes customary events of default that include, among other things, non-payment of principal, interest or fees, inaccuracy of representations and warranties, violation of certain covenants, cross default to certain other indebtedness, bankruptcy and insolvency events, material judgments and change of control. Upon an event of default, the lender may, subject to customary cure rights, require the immediate payment of all amounts outstanding.
At December 31, 2023, the Company was in compliance with all financial covenants contained in the 2021 Credit Agreement and has made no borrowings from the 2021 Credit Facility to date. However, there is an outstanding
letter of credit under the 2021 Credit Agreement of $5.2 million for certain duty-related requirements. This was not collateralized by any cash on hand.
Convertible Notes
2025 Convertible Notes
In November 2020, the Company issued $125.0 million aggregate principal amount of 1.25% Convertible Senior Notes due 2025 and granted an option to the initial purchasers to purchase up to an additional $18.8 million aggregate principal amount of the 2025 Notes to cover over-allotments, of which $18.8 million was subsequently exercised during November 2020, resulting in a total issuance of $143.8 million aggregate principal amount of the 2025 Notes. The 2025 Notes are senior, unsecured obligations of the Company and mature on November 15, 2025, unless earlier repurchased or converted into shares of Class A common stock under certain circumstances. The 2025 Notes are convertible into cash, shares of the Company’s Class A common stock, or a combination thereof, at the Company’s election, at an initial conversion rate of 107.1984 shares of Class A common stock per $1,000 principal amount of the 2025 Notes, which is equivalent to an initial conversion price of approximately $9.3285 per share of common stock, subject to adjustment. The Company pays interest on the 2025 Notes semi-annually in arrears on May 15 and November 15 of each year.
The Company may redeem all or any portion of the 2025 Notes on or after November 20, 2023 for cash if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides the redemption notice, at a redemption price equal to 100% of the principal amount of the 2025 Notes to be redeemed, plus accrued interest and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the 2025 Notes. The indenture includes customary terms and covenants, including certain events of default after which the 2025 Notes may be due and payable immediately.
Holders have the option to convert the 2025 Notes in multiples of $1,000 principal amount at any time prior to August 15, 2025, but only in the following circumstances:
•during any calendar quarter beginning after the calendar quarter ending on March 31, 2021, if the last reported sale price of Class A common stock for at least 20 trading days (whether or not consecutive) during the last 30 consecutive trading days of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price of the 2025 Notes on each applicable trading day;
•during the five-business day period following any five consecutive trading day period in which the trading price for the 2025 Notes is less than 98% of the product of the last reported sale price of Class A common stock and the conversion rate for the 2025 Notes on each such trading day;
•if the Company calls any or all of the 2025 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately before the redemption date; or
•upon the occurrence of specified corporate events.
At any time on or after August 15, 2025 until the second scheduled trading day immediately preceding the maturity date of the 2025 Notes on November 15, 2025, a holder may convert its 2025 Notes, in multiples of $1,000 principal amount. Holders of the 2025 Notes who convert their 2025 Notes in connection with a make-whole fundamental change (as defined in the indenture) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, in the event of a fundamental change prior to the maturity date, holders will, subject to certain conditions, have the right, at their option, to require the Company to repurchase for cash all or part of the 2025 Notes at a repurchase price equal to 100% of the principal amount of the 2025 Notes to be repurchased, plus accrued and unpaid interest up to, but excluding, the repurchase date. During the year ended December 31, 2023, the conditions allowing holders of the 2025 Notes to convert were not met.
In connection with the offering of the 2025 Notes, the Company paid $10.2 million to enter into privately negotiated capped call transactions with certain financial institutions (Capped Calls). The Capped Calls have an initial strike price of $9.3285 per share, which corresponds to the initial conversion price of the 2025 Notes. The Capped Calls cover, subject to anti-dilution adjustments substantially similar to those applicable to the conversion
rate of the 2025 Notes, the number of Class A common stock initially underlying the 2025 Notes. The Capped Calls are generally expected to reduce potential dilution to the Company’s Class A common stock upon any conversion of the 2025 Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted 2025 Notes, as the case may be, with such reduction and/or offset subject to a cap, initially equal to $12.0925, and is subject to certain adjustments under the terms of the Capped Call transactions. The Capped Calls will expire in November 2025, if not exercised earlier.
The Capped Calls are subject to adjustment upon the occurrence of specified extraordinary events affecting the Company, including merger events, tender offers, and announcement events. In addition, the Capped Calls are subject to certain specified additional disruption events that may give rise to a termination of the Capped Calls, including nationalization, insolvency or delisting, changes in law, failures to deliver, insolvency filings and hedging disruptions. For accounting purposes, the Capped Calls are separate transactions, and not part of the terms of the 2025 Notes. As these transactions meet certain accounting criteria, the Capped Calls are recorded in stockholders’ equity as a reduction to additional paid-in capital and will not be remeasured as long as they continue to meet certain accounting criteria.
2022 Convertible Notes
In April 2017, the Company issued $175.0 million aggregate principal amount of 3.50% Convertible Senior Notes due 2022 (2022 Notes), which were repaid in full by their April 15, 2022 maturity date. The 2022 Notes were senior, unsecured obligations of the Company that could be converted into cash, shares of the Company’s Class A common stock, or a combination thereof, at the Company’s election, based on conversion rates as defined in the indenture. Concurrently with the November 2020 issuance of the 2025 Notes, the Company used $56.2 million of the net cash proceeds from the 2025 Notes to repurchase $50.0 million in aggregate principal amount of the 2022 Notes through a single, privately negotiated transaction. On April 15, 2022, the Company repaid the remaining $125.0 million of principal and $2.2 million of accrued interest in cash to the debt holders to fully settle the 2022 Notes on the maturity date.
Accounting for the 2022 and 2025 Convertible Notes
Pre adoption of ASU 2020-06
The 2022 and 2025 Convertible Notes were separated into liability and equity components for accounting purposes. The carrying amounts of the liability component were initially calculated by measuring the fair value of similar liabilities that do not have associated convertible features. The carrying amounts of the equity component representing the conversion option were determined by deducting the fair value of the liability component from the par value of the respective Convertible Senior Notes. This difference represents the debt discount that was amortized to interest expense over the respective terms of the 2022 Notes and 2025 Notes using the effective interest rate method. Upon issuance, the carrying amounts of the liability component from the issuance of the 2022 Notes and the 2025 Notes of $128.3 million and $106.9 million, respectively were recorded in long-term debt on the Consolidated Balance Sheets. The carrying amounts of the equity component representing the conversion option was determined to be $46.7 million and $36.9 million for the 2022 Notes and 2025 Notes, respectively, upon issuance. The equity component was recorded in additional paid-in-capital and was not remeasured so long as it continued to meet the conditions for equity classification.
The liability component was accreted over the debt term up to the face value of the 2022 Notes of $175.0 million and 2025 Notes of $143.8 million, which resulted in non-cash interest expense being recognized in the Consolidated Statements of Operations. The accretion of the 2022 Notes and 2025 Notes to par to long-term debt was amortized into interest expense over the term of the 2022 Note and 2025 Notes using an effective interest rate of approximately 10.5% and 7.5%, respectively.
In accounting for the debt issuance costs of $5.7 million and $4.7 million related to the 2022 Notes and 2025 Notes, respectively, the Company allocated each of the total amounts incurred to the liability and equity components of the 2022 Notes and 2025 Notes based on their relative values. Issuance costs attributable to the liability component of the 2022 Notes were $4.2 million upon issuance and were amortized, along with the debt discount, to interest expense over the contractual term of the 2022 Notes at an effective interest rate of 10.5%. Issuance costs attributable to the liability component of the 2025 Notes were $3.5 million upon issuance and were amortized, along with the debt discount, to interest expense over the contractual term of the 2025 Notes at an
effective interest rate of 7.5%. Issuance costs attributable to the equity component were $1.5 million and $1.2 million for the 2022 Notes and 2025 Notes, respectively, and were netted against the equity component representing the conversion option in additional paid-in-capital.
Post adoption of ASU 2020-06
On January 1, 2022, the Company adopted ASU 2020-06 based on the modified retrospective transition method. Under such transition, prior period information has not been retrospectively adjusted. Upon adoption of ASU 2020-06, the Company is no longer recording the conversion feature of its 2022 Notes and 2025 Notes in equity. Instead, the Company combined the previously separated equity component with the liability component, which together are now classified as debt, thereby eliminating the subsequent amortization of the debt discount as interest expense. Similarly, the portion of debt issuance costs previously allocated to equity was reclassified to debt and amortized as interest expense. Accordingly, the Company recorded a decrease to additional paid-in-capital of $78.2 million, a decrease to accumulated deficit of $47.1 million, and an increase to the debt balance of the 2022 Notes and 2025 Notes of $2.3 million and $28.8 million, respectively. In addition, the Company recorded the reversal of U.S. deferred tax liabilities (net) of $7.3 million associated with the 2022 Notes and 2025 Notes upon the adoption of ASU 2020-06, with a corresponding decrease to accumulated deficit for the same amount.
2022 Convertible Notes
For the year ended December 31, 2023, 2022, and 2021, the Company recorded interest expense of zero, $1.3 million, and $4.4 million for contractual coupon interest, and zero, $0.2 million, and $0.6 million for amortization of debt issuance costs. As of December 31, 2022, the effective interest rate, which is calculated as the contractual interest rate adjusted for the debt issuance costs, was 1.2%. For the year ended December 31, 2023, 2022, and 2021, the Company recorded zero, zero, and $7.8 million respectively, for amortization of debt discount.
2025 Convertible Notes
In November 2023, the Company repurchased $50.0 million in aggregate principal amount of the 2025 Notes in exchange for $46.3 million cash through an individual, privately negotiated transaction. The repurchase was accounted for as a debt extinguishment. The carrying value of the portion of the 2025 Notes repurchased was $49.4 million, and the Company recognized a gain on the debt extinguishment of $3.1 million, which was recorded in the fourth quarter of 2023 within other income (expense), net, on the Company's Consolidated Statements of Operations.
As of December 31, 2023 and 2022, the outstanding principal on the 2025 Notes was $93.8 million and $143.8 million, respectively, the unamortized debt issuance cost was $1.2 million and $2.8 million, respectively, and the net carrying amount of the liability was $92.6 million and $141.0 million, respectively, which was recorded as long-term debt within the Consolidated Balance Sheets. For the year ended December 31, 2023, 2022, and 2021, the Company recorded interest expense of $1.7 million, $1.8 million, and $1.8 million respectively, for contractual coupon interest, and $0.9 million, $1.0 million, and $0.7 million, respectively, for amortization of debt issuance costs. As of December 31, 2023, and 2022, the effective interest rate, which is calculated as the contractual interest rate adjusted for the debt issuance costs, was 2.8% and 1.9%, respectively. For the year ended December 31, 2023, 2022, and 2021, the Company recorded zero, zero, and $6.4 million respectively, for amortization of the debt discount.
v3.24.0.1
Employee benefit plans
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Employee benefit plans
Stock-based compensation. Stock-based awards granted to qualified employees, non-employee directors and consultants are measured at fair value and recognized as an expense. The Company primarily issues restricted stock units and accounts for forfeitures as they occur. For service-based awards, stock-based compensation is recognized on a straight-line basis over the requisite service period. For performance and market-based awards which also require a service period, the Company uses graded vesting over the longer of the derived service period or when the performance or market condition is satisfied.
Compensation and Employee Benefit Plans
6. Employee benefit plans
Equity incentive plans. The Company has outstanding equity grants from its three stock-based employee compensation plans: the 2014 Equity Incentive Plan (2014 Plan), the 2010 Equity Incentive Plan (2010 Plan) and the 2014 Employee Stock Purchase Plan (2014 ESPP). No new options or awards have been granted under the 2010 Plan since June 2014. Outstanding options and awards under the 2010 Plan continue to be subject to the terms and conditions of the 2010 Plan.
The 2014 Plan serves as a successor to the 2010 Plan and provides for the granting of incentive and non-qualified stock options, restricted stock awards (RSAs), restricted stock units (RSUs), stock appreciation rights, stock bonus awards and performance awards to qualified employees, non-employee directors and consultants. Options granted under the 2014 Plan generally expire within ten years from the date of grant and generally vest over one to four years. Restricted stock units (RSUs) granted under the 2014 Plan generally vest over two to four years based upon continued service and are settled at vesting in shares of the Company’s Class A common stock. Performance stock units (PSUs) granted under the 2014 Plan generally vest over three years based upon continued service and the Company achieving certain financial and operating targets and are settled at vesting in shares of the Company’s Class A common stock. The Company accounts for forfeitures of stock-based payment awards in the period they occur.
The 2014 ESPP allows eligible employees to purchase shares of the Company’s Class A common stock through payroll deductions at a price equal to 85% of the lesser of the fair market value of the stock as of the first date or the ending date of each six-month offering period. The 2014 Plan and the ESPP also provide for automatic annual increases in the number of shares reserved for future issuance.
In June 2023, the Company’s stockholders approved the 2024 Equity Incentive Plan (2024 Plan) and the 2024 Employee Stock Purchase Plan (2024 ESPP) which will be the successors to the Company’s 2014 Plan and 2014 ESPP, respectively. The effective date of both the 2024 Plan and the 2024 ESPP is February 15, 2024. The 2014 Plan and the 2014 ESPP will each expire on February 15, 2024. Awards granted under the 2014 Plan will continue to be subject to the terms and provisions of the 2014 Plan.
Employee retirement plan. The Company has a defined contribution retirement plan covering the United States and other international full-time employees that provides for voluntary employee contributions from 1% to 100% of annual compensation, subject to a maximum limit allowed by Internal Revenue Service guidelines. In certain locations, the Company makes contributions to employee defined contribution plans, these contributions were $0.9 million, $0.8 million, and $0.8 million in 2023, 2022, and 2021, respectively.
Stock options
A summary of the Company’s stock option activity is as follows:
Shares
(in thousands)
Weighted-average exercise price
Weighted-average remaining contractual term (in years)
Aggregate intrinsic value (in thousands)
Outstanding at December 31, 20223,089 $9.37 5.30$467 
Granted198 3.58 
Exercised— — 
Forfeited/Cancelled(603)11.64 
Outstanding at December 31, 20232,684 $8.43 5.08$— 
Vested and expected to vest at December 31, 20232,684 $8.43 5.08$— 
Exercisable at December 31, 20232,250 $8.92 4.40$— 
The weighted-average grant date fair value of all options granted was $2.14, $5.05, and $4.62 per share in 2023, 2022, and 2021, respectively. The total fair value of all options vested was $1.4 million, $1.5 million, and $1.5 million in 2023, 2022, and 2021, respectively. The aggregate intrinsic value of the stock options outstanding as of December 31, 2023 represents the value of the Company’s closing stock price on December 31, 2023 in excess of the exercise price multiplied by the number of options outstanding.
Restricted stock units
A summary of the Company’s RSU activity is as follows:
Shares
(in thousands)
Weighted-average grant date fair value
Non-vested shares at December 31, 20228,727 $7.19 
Granted8,595 5.13 
Vested(5,224)6.61 
Forfeited(604)6.68 
Non-vested shares at December 31, 202311,494 $5.94 
The weighted-average grant date fair value of all RSUs granted was $5.13, $7.68, and $8.83 per share in 2023, 2022, and 2021, respectively. The total fair value of all RSUs vested was $34.5 million, $30.8 million, and $28.5 million in 2023, 2022, and 2021, respectively.
Performance stock units
A summary of the Company’s PSU activity is as follows:
Shares
(in thousands)
Weighted-average grant date fair value
Non-vested shares at December 31, 2022686 

$7.93 
Granted1,254 5.79 
Vested(485)7.71 
Forfeited(631)5.86 
Non-vested shares at December 31, 2023824 $6.38 
The weighted-average grant date fair value of all PSUs granted was $5.79, $8.70, and $7.93 per share in 2023, 2022, and 2021, respectively. The total fair value of all PSUs vested was $3.7 million, $4.8 million, and $3.0 million in 2023, 2022, and 2021, respectively.
Employee stock purchase plan. For 2023, 2022, and 2021 the Company issued 0.9 million, 0.7 million, and 0.8 million shares under its ESPP, respectively, at weighted-average prices of $4.10, $6.72, and $5.28 per share, respectively.
Fair value disclosures. The Company measures compensation expense for all stock-based payment awards based on the estimated fair values on the date of the grant. The fair value of RSUs and PSUs are determined using the Company’s closing stock price on the date of grant. The Company recognizes compensation expense for PSUs when it is probable that the vesting conditions will be met. The fair value of stock options granted and purchases under the Company’s ESPP are estimated using the Black-Scholes option pricing model. Expected term of stock options granted was estimated based on the simplified method. Expected stock price volatility was estimated by taking the Company’s average historical volatility. Risk-free interest rate was based on the yields of U.S. Treasury securities with maturities similar to the expected term. Dividend yield was zero as the Company does not have any history of, nor plans to make, dividend payments.
The fair value of stock options granted was estimated as of the grant date using the following assumptions:
Year ended December 31,
202320222021
Volatility
59%-60%
60%-62%
64%
Expected term (years)6.106.106.10
Risk-free interest rate
3.5%-4.5%
2.0%-3.9%
0.7%-1.1%
Dividend yield—%—%—%
The fair value of stock purchase rights granted under the ESPP was estimated using the following assumptions:
Year ended December 31,
202320222021
Volatility
39%-42%
39%-55%
64%-80%
Expected term (years)0.50.50.5
Risk-free interest rate
5.0%-5.6%
0.7%-3.1%
0.1%
Dividend yield—%—%—%
Stock-based compensation expense. The following table summarizes stock-based compensation expense included in the Consolidated Statements of Operations:
Year ended December 31,
(in thousands)
202320222021
Cost of revenue
$1,955 $1,805 $1,794 
Research and development
19,062 17,221 17,263 
Sales and marketing
8,736 8,173 8,045 
General and administrative
11,726 11,792 11,548 
Total stock-based compensation expense$41,479 $38,991 $38,650 
The income tax benefit related to stock-based compensation expense was $9.3 million, $8.6 million and $9.0 million for the year ended December 31, 2023, 2022, and 2021 respectively. See Note 8, Income taxes, for additional details.
As of December 31, 2023, total unearned stock-based compensation of $57.0 million related to stock options, RSUs, PSUs, and ESPP shares is expected to be recognized over a weighted-average period of 2.24 years.
v3.24.0.1
Net loss per share
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Net loss per share
Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of shares of common stock outstanding. Diluted net income per share adjusts the basic net income per share and the weighted-average number of shares of common stock outstanding for the potentially dilutive impact of the Company’s ESPP and stock awards, using the treasury stock method. The Company calculated the potential dilutive effect of its 2022 Notes and 2025 Notes under the if-converted method. Under the if-converted method, diluted net income per share was determined by assuming all of the 2022 Notes and the 2025 Notes were converted into shares of the Company’s Class A common stock at the beginning of the reporting period. In addition, in periods of net income, interest charges on the 2022 Notes and 2025 Notes, which includes both coupon interest and amortization of debt issuance costs, were added back to net income on an after-tax effected basis.
Prior to the adoption of ASU 2020-06, the Company calculated the potential dilutive effect of its 2022 Notes and 2025 Notes under the treasury stock method. As a result, only the amount by which the conversion value exceeded the aggregate principal amount of the 2022 Notes and 2025 Notes (the conversion spread) was considered in the diluted net income (loss) per share computation. The conversion spread was dilutive in periods of net income when the average market price of the Company’s Class A common stock for a given reporting period exceeded the initial conversion prices of $10.64 and $9.3285 per share for the 2022 Notes and 2025 Notes, respectively. For the year ended December 31, 2021, only the conversion spread relating to the 2025 Notes had a dilutive effect on net income per share. The initial conversion price of the 2022 Notes was greater
than the average market price of the Company’s Class A Common Stock for the year ended December 31, 2021, and as such, had no impact on anti-dilutive or dilutive share calculations. Upon conversion of the 2025 Notes, there will be no economic dilution until the average market price of the Company’s Class A common stock exceeds the cap price of $12.0925 per share, as exercise of the Capped Calls offset any dilution from the 2025 Notes from the initial conversion price up to the cap price. The Capped Calls are excluded from diluted net income per share as they would be anti-dilutive.
The Company’s 2022 Notes matured on April 15, 2022, and the Company’s 2025 Notes will mature on November 15, 2025, unless earlier repurchased or converted into shares of Class A common stock under certain circumstances as described further in Note 4 Financing arrangements. The 2025 Notes are convertible into cash, shares of the Company’s Class A common stock, or a combination thereof, at the Company’s election.
The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share and each share of Class B common stock is entitled to ten votes per share. Each share of Class B common stock is convertible at any time at the option of the stockholder into one share of Class A common stock and has no expiration date. Each share of Class B common stock will convert automatically into one share of Class A common stock upon the date when the outstanding shares of Class B common stock represent less than 10% of the aggregate number of shares of common stock then outstanding. Class A common stock is not convertible into Class B common stock. The computation of the diluted net income (loss) per share of Class A common stock assumes the conversion of Class B common stock.
v3.24.0.1
Income taxes
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Income taxes
8. Income taxes
Income (loss) before income taxes consisted of the following:
Year ended December 31,
(in thousands)
202320222021
United States$(79,514)$26,215 $83,419 
Foreign11,781 8,238 6,681 
Income (loss) before income taxes$(67,733)$34,453 $90,100 
Income tax expense (benefit) consisted of the following:
Year ended December 31,
(in thousands)
202320222021
Current
Federal$3 $2 $(128)
State162 818 267 
Foreign3,176 2,076 (7,669)
Total current3,341 2,896 (7,530)
Deferred
Federal(14,018)5,039 (205,856)
State(3,828)(2,312)(67,933)
Foreign(45)(17)248 
Total deferred(17,891)2,710 (273,541)
Income tax expense (benefit)$(14,550)$5,606 $(281,071)
Year ended December 31,
202320222021
(dollars in thousands)
$%$%
$
%
Reconciliation to statutory rate
Tax at federal statutory rate$(14,224)21.0 %$7,234 21.0 %$18,921 21.0 %
Impact of foreign operations2,969 (4.4)1,572 4.6 (8,222)(9.2)
Stock-based compensation3,434 (5.1)(1,192)(3.5)(5,345)(5.9)
Nondeductible items557 (0.8)1,805 5.2 1,684 1.9 
Change in valuation allowance— — — — (284,551)(315.8)
State income taxes, net of federal benefit(1,560)2.3 1,189 3.5 1,828 2.0 
Tax credits(5,474)8.1 (5,222)(15.1)(6,091)(6.8)
Other(252)0.4 220 0.6 705 0.8 
Income tax expense (benefit) at effective tax rate$(14,550)21.5 %$5,606 16.3 %$(281,071)(312.0)%

The effective tax rate of 21.5% for 2023, primarily resulted from a tax benefit on pre-tax book loss, and federal and California research and development credits, partially offset by the nondeductible equity tax expense from stock-based compensation and the impact of foreign operations, net of the release of a portion of uncertain tax positions as a result of a lapse in the statute of limitations in certain jurisdictions. The effective tax rate of 16.3% for 2022, primarily resulted from tax expense on pre-tax book income, partially offset by the income tax benefits from stock-based compensation, federal and California research and development credits, and an income tax benefit related to foreign provision to income tax return adjustments.
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and deferred tax liabilities were as follows:

Year ended December 31,
(in thousands)
20232022
Deferred tax assets:
Net operating loss carryforwards$109,059 $118,399 
Tax credit carryforwards96,610 91,147 
Stock-based compensation5,966 6,034 
Allowance for returns1,823 1,818 
Intangible assets2,727 3,753 
Depreciation and amortization988 1,661 
Operating lease liabilities8,326 10,177 
Capitalized research and development costs55,266 29,122 
Accruals and reserves20,540 22,001 
Total deferred tax assets$301,305 $284,112 
Deferred tax liabilities:
Operating lease right-of-use assets(4,321)(5,072)
Total deferred tax liabilities(4,321)(5,072)
Net deferred tax assets$296,984 $279,040 

Each quarter, the Company assesses the recoverability of its existing deferred tax assets under ASC Topic 740. The Company assesses available positive and negative evidence and uses judgment regarding past and future events, including operating results to estimate whether sufficient future taxable income will be generated to use its
existing deferred tax assets. For the period ended December 31, 2023, based on evidence currently available, the Company continues to believe that it is more likely than not that its United States federal, state, and foreign deferred tax assets will be realized and thus, a valuation allowance is not required on its deferred tax assets. The Company continuously monitors future projections of its operating results to determine the potential impact regarding its assessment of the recoverability of deferred tax assets in each of its applicable jurisdictions. In the event there is a need to record a valuation allowance or release a valuation allowance, as applicable, a tax expense or benefit would be recorded, which may be material to the Company’s consolidated financial statements.
As of December 31, 2023, the Company’s federal, California, and other state net operating loss carryforwards for income tax purposes were $394.1 million, $243.1 million, and $169.8 million, net of reserves, respectively. Also, the Company’s federal and California state tax credit carryforwards were $54.4 million and $53.4 million, net of reserves, respectively. If not utilized, federal net operating losses that arose before 2018 and California loss carryforwards will begin to expire from 2035 to 2043, while federal credit and other state loss carryforwards will begin to expire primarily from 2024 to 2043. Federal net operating losses that arose after 2017 and all California tax credits will be carried forward indefinitely.
Uncertain income tax positions. The Company had gross unrecognized tax benefits of $25.8 million, $23.4 million, and $21.3 million, as of December 31, 2023, 2022, and 2021, respectively. For fiscal year 2023, 2022, and 2021, total unrecognized income tax benefits were $10.9 million, $9.8 million, and $7.3 million, respectively, and if recognized, would reduce income tax expense. A material portion of the Company’s gross unrecognized tax benefits, if recognized, would increase the Company’s net operating loss carryforward.
The Company conducts business globally and as a result, files income tax returns in the United States and foreign jurisdictions. The Company’s unrecognized tax benefits relate primarily to unresolved matters with taxing authorities. While it is often difficult to predict the final outcome or the timing of resolution of any particular uncertain tax position, the Company believes that its reserves reflect the more likely outcome. The Company believes, due to statute of limitations expiration, that within the next 12 months, it is possible that up to $2.9 million of uncertain tax positions could be released. It is also reasonably possible that additional uncertain tax positions will be added. It is not reasonably possible at this time to quantify the net effect.
A reconciliation of the beginning and ending amount of gross unrecognized income tax benefits are as follows:
Year ended December 31,
(in thousands)
202320222021
Balance at January 1$23,414 $21,330 $27,471 
Increase related to current year tax positions4,948 2,543 3,081 
Increase related to prior year tax positions— — 3,900 
Decrease related to prior year tax positions(2,526)(459)(13,122)
Balance at December 31$25,836 $23,414 $21,330 
The Company’s policy is to account for interest and penalties related to income tax liabilities within the provision for income taxes. The balances of accrued interest and penalties recorded in the balance sheets and provision were not material for any period presented.
The Company files income tax returns in the United States and in foreign jurisdictions. As of December 31, 2023, the Company continues to assert indefinite reinvestment to the extent of any foreign withholding taxes on the undistributed earnings related to these foreign branches. Any foreign withholding tax on these earnings is deemed not to be material.
v3.24.0.1
Commitments, contingencies and guarantees
 12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments, contingencies and guarantees
9. Commitments, contingencies, and guarantees
Facility leases. The Company leases its facilities under long-term operating leases, which expire at various dates through 2029.
The components of net lease cost, which were primarily recorded in operating expenses, were as follows:
Year ended December 31,
(in thousands)202320222021
Operating lease cost (1)
$11,045 $11,060 $11,566 
Sublease income(2,281)(2,907)(964)
Net lease cost$8,764 $8,153 $10,602 
(1)    Operating lease cost includes variable lease costs, which are immaterial.

Supplemental cash flow information related to leases was as follows:
Year ended December 31,
(in thousands)202320222021
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases$12,217 $14,595 $14,902 
Right-of-use assets obtained in exchange for operating lease liabilities3,943 1,221 2,475 
Operating lease modification to decrease right-of-use assets— (232)— 

Supplemental balance sheet information related to leases was as follows:
December 31, 2023December 31, 2022
Weighted-average remaining lease term (in years) - operating leases3.053.81
Weighted-average discount rate - operating leases6.2%6.1%

As of December 31, 2023, maturities of operating lease liabilities were as follows:
(in thousands)
December 31, 2023
2024$12,488 
202513,141 
202612,361 
20271,359 
2028401 
Thereafter103 
Total lease payments39,853 
Less: Imputed interest(3,806)
Present value of lease liabilities$36,047 
Other commitments. In the ordinary course of business, the Company enters into multi-year agreements to purchase sponsorships with event organizers, resorts, and athletes as part of its marketing efforts; software licenses related to its financial and IT systems; debt agreements; and various other contractual commitments. As of December 31, 2023, future commitments were as follows:
(in thousands)
Total20242025202620272028Thereafter
Other contractual commitments$50,996 $36,045 $10,278 $4,673 $— $— $— 
Long-term debt (1)
96,081 1,159 94,922 — — — — 
Total contractual cash obligations
$147,077 $37,204 $105,200 $4,673 $— $— $— 
(1)    The Company's convertible senior note is due in November 2025. The balances include accrued and unpaid interest as of December 31, 2023. Refer to Note 4 Financing arrangements.
Legal proceedings and investigations. Since 2015, Contour IP Holdings LLC (CIPH) and related entities have filed lawsuits in various federal district courts alleging, among other things, patent infringement in relation to certain GoPro products. Following litigation in federal courts and the United States Patent and Trademark Office, CIPH’s patents were ruled invalid in March 2022. Judgment was then entered in favor of the Company and against CIPH. CIPH later appealed, and the appeal is pending at the Federal Circuit. The Company believes that the appeal lacks merit and intends to vigorously defend against CIPH's appeal.
The Company regularly evaluates the associated developments of the legal proceeding described above, as well as other legal proceedings that arise in the ordinary course of business. While litigation is inherently uncertain, based on the currently available information, the Company is unable to determine a loss or a range of loss, and does not believe the ultimate cost to resolve these matters will have a material adverse effect on its business, financial condition, cash flows or results of operations.
Indemnifications. The Company has entered into indemnification agreements with its directors and executive officers which requires the Company to indemnify its directors and executive officers against liabilities that may arise by reason of their status or service. In addition, in the normal course of business, the Company enters into agreements that contain a variety of representations and warranties, and provide for general indemnification. The Company’s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future but have not yet been made. It is not possible to determine the maximum potential amount under these indemnification agreements due to the Company’s limited history with indemnification claims and the unique facts and circumstances involved in each particular agreement. As of December 31, 2023, the Company has not paid any claims, nor has it been required to defend any action related to its indemnification obligations. However, the Company may record charges in the future as a result of these indemnification obligations.
v3.24.0.1
Concentrations of risk and geographic information
 12 Months Ended
Dec. 31, 2023
Risks and Uncertainties [Abstract]  
Concentrations of risk and segment information Concentrations of risk and geographic information
Concentration of risk. Financial instruments which potentially subject the Company to concentration of credit risk includes cash and cash equivalents, marketable securities, accounts receivable, and derivative instruments, including the Capped Calls associated with the 2025 Notes. The Company places cash and cash equivalents with high-credit-quality financial institutions; however, the Company maintains cash balances in excess of the FDIC insurance limits. The Company believes that credit risk for accounts receivable is mitigated by the Company’s credit evaluation process, relatively short collection terms and dispersion of its customer base. The Company generally does not require collateral and losses on trade receivables have historically been within the Company’s expectations. The Company believes its counterparty credit risk related to its derivative instruments is mitigated by transacting with major financial institutions with high credit ratings.
Customers who represented 10% or more of the Company’s net accounts receivable balance were as follows:
December 31, 2023December 31, 2022
Customer A30%30%
Customer B11%11%
The following table summarizes the Company’s accounts receivables sold, without recourse, and factoring fees paid:
Year ended December 31,
(in thousands)
202320222021
Accounts receivable sold$103,990 $124,350 $108,625 
Factoring fees1,555 1,163 488 
Third-party customers who represented 10% or more of the Company's total revenue were as follows:
Year ended December 31,
202320222021
Customer A**11%
* Less than 10% of total revenue for the periods indicated.
Supplier concentration. The Company relies on third parties for the supply and manufacture of its products, some of which are sole-source suppliers. The Company believes that outsourcing manufacturing enables greater scale and flexibility. As demand and product lines change, the Company periodically evaluates the need and advisability of adding manufacturers to support its operations. In instances where a supply and manufacture agreement does not exist or suppliers fail to perform their obligations, the Company may be unable to find alternative suppliers or satisfactorily deliver its products to its customers on time, if at all. The Company also relies on third parties with whom it outsources supply chain activities related to inventory warehousing, order fulfillment, distribution and other direct sales logistics. In instances where an outsourcing agreement does not exist or these third parties fail to perform their obligations, the Company may be unable to find alternative partners or satisfactorily deliver its products to its customers on time.
Geographic information
Revenue by geographic region, based on ship-to locations, was as follows:
Year ended December 31,2023 vs 20222022 vs 2021
(in thousands)
202320222021
% Change
% Change
Americas
$469,675 $521,270 $607,534 (10)%(14)%
Europe, Middle East and Africa (EMEA)290,814 300,870 305,654 (3)(2)
Asia and Pacific (APAC)
244,970 271,401 247,896 (10)9 
Total revenue
$1,005,459 $1,093,541 $1,161,084 (8)%(6)%
Revenue from the United States, which is included in the Americas geographic region, was $388.0 million, $446.0 million, and $526.5 million for 2023, 2022, and 2021, respectively. No other individual country exceeded 10% of total revenue for any period presented. The Company does not disclose revenue by product category as it does not track sales incentives and other revenue adjustments by product category to report such data.
As of December 31, 2023 and 2022, long-lived assets, which represent net property and equipment, located outside the United States, primarily in Hong Kong and mainland China, were $1.6 million and $4.0 million, respectively.
v3.24.0.1
Restructuring charges
 12 Months Ended
Dec. 31, 2023
Restructuring and Related Activities [Abstract]  
Restructuring charges Restructuring charges
Restructuring charges for each period were as follows:
Year ended December 31,
(in thousands)
202320222021
Cost of revenue
$(90)$8,090 $70 
Research and development
687 244 600 
Sales and marketing
130 137 361 
General and administrative
11 77 195 
Total restructuring charges
$738 $8,548 $1,226 
Fourth quarter 2022 restructuring
In December 2022, the Company approved a restructuring plan to reduce camera production-related costs by globally realigning its manufacturing footprint to concentrate production activities in two primary locations: China
and Thailand. Under the fourth quarter 2022 restructuring, the Company recorded restructuring charges of $8.1 million including $7.0 million for camera production line closure costs and $1.1 million for related transitional costs to migrate production to the Company’s remaining manufacturing locations.
The following table provides a summary of the Company’s restructuring activities and the movement in the related liabilities recorded in accrued expenses and other current liabilities on the Consolidated Balance Sheets under the fourth quarter 2022 restructuring.
(in thousands)
Contract and Other Costs
Total
Restructuring liability as of December 31, 2022$7,833 $7,833 
Restructuring charges (releases)(184)(184)
Cash paid
(7,649)(7,649)
Restructuring liability as of December 31, 2023$— $— 
v3.24.0.1
Subsequent Events
 12 Months Ended
Dec. 31, 2023
Subsequent Event [Line Items]  
Subsequent Events [Text Block]
12. Subsequent events
In January 2024, the Company entered into an agreement to acquire a privately-held company that offers technology-enabled helmets. The transaction is expected to close in the first quarter of 2024, subject to the satisfaction of customary closing conditions.
v3.24.0.1
Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2023
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]
Schedule II
GoPro, Inc.
VALUATION AND QUALIFYING ACCOUNTS
For the year ended December 31, 2023, 2022 and 2021
(in thousands)Balance at Beginning of YearCharges to RevenueCharges (Benefits) to ExpenseCharges to Other Accounts - EquityDeductions/Write-offsBalance at End of Year
Allowance for doubtful accounts receivable:
Year ended December 31, 2023$390 $— $67 $— $(7)$450 
Year ended December 31, 2022700 — (294)— (16)390 
Year ended December 31, 2021492 — 393 — (185)700 
Valuation allowance for deferred tax assets:
Year ended December 31, 2023$— $— $— $— $— $— 
Year ended December 31, 2022— — — — — — 
Year ended December 31, 2021287,276 — (284,551)— (2,725)— 
v3.24.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Pay vs Performance Disclosure      
Net income (loss) $ (53,183) $ 28,847 $ 371,171
v3.24.0.1
Insider Trading Arrangements
 12 Months Ended
Dec. 31, 2023
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Trading Plans of Directors and Executive Officers
None of the Company’s directors or officers adopted, modified, or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the Company’s fourth quarter ended December 31, 2023, as such terms are defined under Item 408(a) of Regulation S-K.
v3.24.0.1
Summary of business and significant accounting policies (Policies)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Basis of presentation
Basis of presentation. The accompanying consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (GAAP) for financial information set forth in the Accounting Standards Codification (ASC), as published by the Financial Accounting Standards Board (FASB), and with the applicable rules and regulations of the Securities and Exchange Commission (SEC). The Company’s fiscal year ends on December 31, and its fiscal quarters end on March 31, June 30, and September 30.
The consolidated financial statements reflect all adjustments, which are normal and recurring in nature, that management believes are necessary for the fair statement of the Company's financial statements, but are not necessarily indicative of the results expected for any other future period.
Principles of consolidation
Principles of consolidation. These consolidated financial statements include all the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of estimates Use of estimates. The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the Company’s consolidated financial statements and accompanying notes. Significant estimates and assumptions made by management include those related to revenue recognition and the allocation of the transaction price (including sales incentives, sales returns, and implied post contract support), inventory valuation, product warranty liabilities, the valuation, impairment and useful lives of long-lived assets (property and equipment, operating lease right-of-use assets, intangible assets and goodwill), fair value of convertible senior notes, and income taxes. The Company bases its estimates and assumptions on historical experience and on various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from management’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations could be affected.
Comprehensive income (loss) Comprehensive income (loss). For all periods presented, comprehensive income (loss) approximated net income (loss). Therefore, the Consolidated Statements of Comprehensive Income (Loss) have been omitted
Cash, Cash Equivalents, and Marketable Securities
Cash equivalents and marketable securities. Cash equivalents consist of investments in money market funds with maturities of three months or less from the date of purchase. Marketable securities consist of U.S. treasury securities, commercial paper, government securities and corporate debt securities, and are classified as available-for-sale securities. The Company views these securities as available to support current operations and has classified all available-for-sale securities as current assets. Available-for-sale securities are carried at fair value with unrealized gains and losses, if any, included in stockholders’ equity. Unrealized gains and losses are charged against other income (expense), net, for declines in fair value below the cost of an individual investment that is deemed to be other than temporary. The Company has not identified any marketable securities as other-than-temporarily impaired for the periods presented. The cost of securities sold is based upon a specific identification method.
Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy
Accounts receivable. Accounts receivable are stated at invoice value less estimated allowances for doubtful accounts. Allowances are recorded based on the Company’s assessment of various factors, such as: historical experience, credit quality of its customers, age of the accounts receivable balances, geographic related risks, economic conditions and other factors that may affect a customer’s ability to pay. The allowance for doubtful accounts as of December 31, 2023 and 2022, was $0.5 million and $0.4 million, respectively.
Inventory, Policy
Inventory. Inventory consists of finished goods and component parts, which are purchased directly from contract manufacturers or from suppliers. Inventory is stated at the lower of cost or net realizable value on a first-in, first-out basis. The Company writes down its inventory for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and estimated market value plus the estimated cost to sell. The Company’s assessment of market value is based upon assumptions around market conditions and estimated future demand for its products within a specified time horizon, generally 12 months, product life cycle status, product development plans and current sales levels. Adjustments to reduce inventory to net realizable value are recognized in cost of revenue.
Advertising Costs, Policy, Capitalized Direct Response Advertising Point of purchase (POP) displays. The Company provides retailers with POP displays, generally free of charge, in order to facilitate the marketing of the Company’s products within retail stores. The POP displays contain a display that broadcasts video images taken by GoPro cameras along with product placement available for cameras and accessories. POP display costs are capitalized as long-term assets and charged to sales and marketing expense over the expected period of benefit, which generally ranges from 24 to 36 months. Cash outflows and amortization related to POP displays are classified as operating activities in the Consolidated Statement of Cash Flows.
Property, Plant and Equipment, Policy
Property and equipment, net. Property and equipment are stated at cost and are depreciated using the straight-line method over the estimated useful life of the assets, ranging from one to nine years. Leasehold improvements are amortized over the shorter of the lease term or their expected useful life. Property and equipment pending installation, configuration or qualification are classified as construction in progress. Costs of maintenance and repairs that do not improve or extend the lives of the respective assets are expensed as incurred.
Fair Value Measurement, Policy
Fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the reporting date. The Company estimates and categorizes the fair value of its financial assets by applying the following hierarchy:
Level 1
Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to directly access.
Level 2
Valuations based on quoted prices for similar assets or liabilities; valuations for interest-bearing securities based on non-daily quoted prices in active markets; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.
Level 3
Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
Leases
Leases. The Company leases its office space and facilities under cancelable and non-cancelable operating leases. Operating leases are presented as operating lease right-of-use (ROU) assets, short-term operating lease liabilities and long-term operating lease liabilities on the Company’s Consolidated Balance Sheets. ROU assets represent the Company’s right to control the use of an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease.
Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of future lease payments. The Company determines its incremental borrowing rate based on the approximate rate at which the Company would borrow, on a secured basis, to calculate the present value of future lease payments. Lease expenses are recognized on a straight-line basis over the lease term. Certain leases include an option to renew with terms that can extend the lease term from one to five years. The exercise of a lease renewal option is at the Company’s sole discretion and is included in the lease term when the Company is reasonably certain it will exercise the option.
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy
Impairment of goodwill and long-lived assets. The Company performs an annual assessment of its goodwill during the fourth quarter of each calendar year or more frequently if indicators of potential impairment exist, such as an adverse change in business climate or a decline in the overall industry demand, that would indicate it is more likely than not that the fair value of its single reporting unit is less than its carrying value. Based on the Company’s assessment as of December 31, 2023, and despite the reduction in the Company’s market capitalization during the second half of 2023, the Company did not record any impairment of goodwill for any periods presented. If the Company's market capitalization continues to decline or future performance varies from current expectations, assumptions, or estimates, including assumptions related to current macroeconomic uncertainties, this may trigger a future impairment charge, which could have a material adverse effect on the Company’s business, financial condition, and results of operations. The Company will continue to monitor developments, including updates to the Company’s financial forecasts and the Company’s market capitalization. Other indefinite-lived intangible assets are assessed for impairment at least annually. If their carrying value exceeds the estimated fair value, the difference is recorded as an impairment.
Long-lived assets, such as property and equipment, intangible assets subject to amortization, and right-of-use assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability of assets to be held and used is measured by comparing the carrying amount to the estimated future undiscounted cash flows expected to be generated by the asset group. If it is determined that an asset group is not recoverable, an impairment charge is recognized for the amount by which the carrying amount of the asset group exceeds its fair value. The Company did not record any impairment charges in 2023, 2022, or 2021.
Standard Product Warranty, Policy Warranty. The Company records a liability for estimated product warranty costs at the time product revenue is recognized. The Company’s standard warranty obligation to its end-users generally provides a 12-month warranty coverage on all of its products except in the European Union where the Company provides a 24-month warranty. The Company also offers extended warranty programs for a fee. The Company’s estimate of costs to service its warranty obligations is based on its historical experience of repair and replacement of the associated products and expectations of future conditions. The warranty obligation is affected by product failure rates and the related use of materials, labor costs and freight incurred in correcting any product failure.
Debt, Policy
Convertible Senior Notes. In April 2017, the Company issued $175.0 million aggregate principal amount of 3.50% Convertible Senior Notes due April 15, 2022 (2022 Notes). In November 2020, the Company issued $143.8 million aggregate principal amount of 1.25% Convertible Senior Notes due November 15, 2025 (2025 Notes). Concurrently with the issuance of the 2025 Notes, the Company used a portion of the net proceeds to repurchase part of the 2022 Notes. The Company repaid the remaining principal amount of $125.0 million of the 2022 Notes and $2.2 million in interest on the 2022 Notes at maturity on April 15, 2022. In November 2023, the Company repurchased $50.0 million in aggregate principal amount of the 2025 Notes. This partial extinguishment of the 2025 Notes resulted in a gain of $3.1 million recognized in the fourth quarter of 2023. See Note 4 Financing arrangements for additional details.
In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This accounting standard update, which was adopted effective January 1, 2022, had a significant impact on the ongoing accounting of the 2022 and 2025 Convertible Senior Notes. Due to the adoption of this accounting standard update under the modified retrospective method, prior periods were not restated. Refer to Note 4 Financing arrangements section below for additional details on the adoption of this accounting standard update.
The Company accounts for its 2022 Notes and 2025 Notes in accordance with ASC 470-20, Debt with Conversion and Other Options. The Company’s 2022 Notes and 2025 Notes have a net settlement feature and may be settled wholly or partially in cash upon conversion. Therefore, the Company calculates the potential dilutive effect of its
2022 Notes and 2025 Notes under the if-converted method. The Company classifies its 2022 Notes and 2025 Notes as debt. Debt issuance costs are also classified as debt and amortized as interest expense.
Revenue recognition
Revenue recognition. The Company derives substantially all of its revenue from the sale of cameras, mounts, accessories, subscription and service, and implied post contract support to customers. The transaction price recognized as revenue represents the consideration the Company expects to be entitled to and is primarily comprised of product revenue, net of returns and variable consideration, which includes sales incentives provided to customers.
The Company’s camera sales contain multiple performance obligations that can include the following four separate obligations: (i) a camera hardware component (which may be bundled with hardware accessories) and the embedded firmware essential to the functionality of the camera component delivered at the time of sale, (ii) a subscription and service, (iii) the implied right for the customer to receive post contract support after the initial sale (PCS), and (iv) the implicit right to the Company’s downloadable free apps and software solutions. The Company’s PCS includes the right to receive, on a when and if available basis, future unspecified firmware upgrades and features as well as bug fixes, and email, chat, and telephone support.
The Company recognizes revenue from its sales arrangements when control of the promised goods or services are transferred to its customers, in an amount that reflects the amount of consideration expected to be received in exchange for the transferred goods or services. For the sale of hardware products, including related firmware and free software solutions, revenue is recognized when transfer of control occurs at a point in time, which generally is at the time the hardware product is shipped and collection is considered probable. For customers who purchase products directly from GoPro.com, the Company retains a portion of the risk of loss on these sales during transit, which are accounted for as fulfillment costs. For PCS, revenue is recognized ratably over 24 months, which represents the estimated period PCS is expected to be provided based on historical experience.
The Company’s subscription and service revenue is recognized primarily from its Premium and Quik subscription offerings and is recognized ratably over the subscription term, with any payments received in advance of services rendered recorded as deferred revenue. The Company launched a Premium+ subscription in February 2024, which includes cloud storage up to 500 gigabytes (GB) of non-GoPro content, HyperSmooth Pro, and the features included in the Premium subscription. The Company’s Premium subscription offers a range of services, including unlimited cloud storage of GoPro content supporting source video and photo quality, damaged camera replacement, cloud storage up to 25 GB of non-GoPro content, Quik desktop editing tools, which was launched in February 2024, highlight videos automatically delivered via the Company’s mobile app when GoPro camera footage is uploaded to a GoPro cloud account using Auto Upload, access to a high-quality live streaming service on GoPro.com as well as discounts on GoPro cameras, gear, mounts and accessories. The Company also offers the Quik subscription that provides access to a suite of simple single-clip and multi-clip editing tools.
For the Company’s camera sale arrangements with multiple performance obligations, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells its products, and subscription and service. If a standalone selling price is not directly observable, then the Company estimates the standalone selling prices considering market conditions and entity-specific factors. For example, the standalone selling price for PCS is determined based on a cost-plus approach, which incorporates the level of support provided to customers, estimated costs to provide such support, and the amount of time and costs that are allocated to efforts to develop the undelivered elements.
The Company’s standard terms and conditions of sale for non-web-based sales do not allow for product returns other than under warranty. However, the Company grants limited rights of return, primarily to certain large retailers. The Company reduces revenue and cost of sales for the estimated returns based on analyses of historical return trends by customer class and other factors. An estimated return liability along with a right to recover assets are recorded for future product returns. Return trends are influenced by product life cycles, new product introductions, market acceptance of products, product sell-through, the type of customer, seasonality, and other factors. Return rates may fluctuate over time but are sufficiently predictable to allow the Company to estimate expected future product returns.
The Company provides sales commissions to internal and external sales representatives which are earned in the period in which revenue is recognized. As a result, the Company expenses sales commissions as incurred.
Deferred revenue as of December 31, 2023 and 2022, includes amounts related to the Company’s subscriptions and PCS. The Company’s short-term and long-term deferred revenue balances totaled $59.1 million and $60.4 million as of December 31, 2023 and 2022, respectively. During the year ended December 31, 2023 and 2022, the Company recognized $57.2 million and $43.1 million of revenue that was included in the deferred revenue balance as of December 31, 2022 and 2021, respectively.
Revenue Recognition, Incentives Sales incentives. The Company offers sales incentives through various programs, including cooperative advertising, price protection, marketing development funds, and other incentives. Sales incentives are considered to be variable consideration, which the Company estimates and records as a reduction to revenue at the date of sale. The Company estimates sales incentives based on historical experience, product sell-through, and other factors.
Shipping and Handling Cost, Policy Shipping costs. Amounts billed to customers for shipping and handling are classified as revenue, and the Company’s related shipping and handling costs incurred are classified as cost of revenue.
Sales Taxes Sales taxes. Sales taxes collected from customers and remitted to respective governmental authorities are recorded as liabilities and are not included in revenue.
Advertising Cost Advertising costs. Advertising costs consist of costs associated with print, television, and e-commerce media advertisements and are expensed as incurred. The Company incurs promotional expenses resulting from payments under event, resort, and athlete sponsorship contracts. These sponsorship arrangements are considered to be executory contracts and, as such, the costs are expensed as performance under the contract is received. The costs associated with the preparation of sponsorship activities, including the supply of GoPro products, media team support, and activation fees are expensed as incurred. Prepayments made under sponsorship agreements are included in prepaid expenses or other long-term assets depending on the period to which the prepayment applies. Advertising costs were $44.1 million, $40.8 million, and $35.8 million in 2023, 2022, and 2021, respectively.
Employee benefit plans
Stock-based compensation. Stock-based awards granted to qualified employees, non-employee directors and consultants are measured at fair value and recognized as an expense. The Company primarily issues restricted stock units and accounts for forfeitures as they occur. For service-based awards, stock-based compensation is recognized on a straight-line basis over the requisite service period. For performance and market-based awards which also require a service period, the Company uses graded vesting over the longer of the derived service period or when the performance or market condition is satisfied.
Foreign Currency Transactions and Translations Policy Foreign currency. The U.S. dollar is the functional currency of the Company’s foreign subsidiaries. The Company remeasures monetary assets or liabilities denominated in currencies other than the U.S. dollar using exchange rates prevailing on the balance sheet date, and non-monetary assets and liabilities at historical rates. Foreign currency remeasurement and transaction gains and losses are included in other income (expense), net and have not been material for any periods presented.
Income Tax, Policy
Income taxes. The Company utilizes the asset and liability method for computing its income tax provision, under which, deferred tax assets and liabilities are recognized for the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates. Management makes estimates, assumptions, and judgments to determine the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income in each tax jurisdiction and, to the extent the Company believes recovery is not likely, establishes a valuation allowance.
The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits are recognized within income tax expense.
Segment information
Segment information. The Company operates as one operating segment as it only reports financial information on an aggregate and consolidated basis to its Chief Executive Officer, who is the Company’s chief operating decision maker.
Goodwill and Intangible Assets, Goodwill, Policy
Goodwill and acquired intangible assets. Goodwill represents the excess of the purchase price over the fair value of the net assets acquired in a business combination. Acquired intangible assets other than goodwill are amortized over their useful lives unless the lives are determined to be indefinite. For intangible assets acquired in a business combination, the determination of the estimated fair values of the assets received involves significant
judgments and estimates. These judgments can include, but are not limited to, the cash flows that an asset is expected to generate in the future, technology obsolescence, and the appropriated weighted-average cost of capital. Valuation approaches consistent with the market approach, income approach and/or cost approach are used to measure fair value.
v3.24.0.1
Equity (Policies) - USD ($)
 12 Months Ended
Dec. 31, 2023
Feb. 09, 2023
Jan. 27, 2022
Equity [Abstract]      
Stockholders' Equity, Policy
5. Stockholders’ equity
Common stock. The Company has two classes of authorized common stock: Class A common stock with 500 million shares authorized and Class B common stock with 150 million shares authorized. As of December 31, 2023, 123.6 million shares of Class A stock were issued and outstanding and 26.3 million shares of Class B stock were issued and outstanding. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting power and conversion rights. Each share of Class A common stock is entitled to one vote per share and each share of Class B common stock is entitled to ten votes per share. Each share of Class B common stock is convertible at any time at the option of the stockholder into one share of Class A common stock and has no expiration date. The Class B common stock is also convertible into Class A common stock on the same basis upon any transfer, whether or not for value, except for “permitted transfers” as defined in the Company’s restated certificate of incorporation. Each share of Class B common stock will convert automatically into one share of Class A common stock upon the date when the outstanding shares of Class B common stock represent less than 10% of the aggregate number of shares of common stock then outstanding. As of December 31, 2023, the Class B stock continued to represent greater than 10% of the overall outstanding shares.
The Company had the following shares of common stock reserved for issuance upon the exercise of equity instruments as of December 31, 2023:
(in thousands)
December 31, 2023
Stock options outstanding
2,684 
Restricted stock units outstanding
11,494 
Performance stock units outstanding
1,441 
Common stock available for future grants
37,414 
Total common stock shares reserved for issuance53,033 
Stock Repurchase Program. On January 27, 2022, the Company’s board of directors authorized the repurchase of up to $100 million of its Class A common stock, and on February 9, 2023, the Company’s board of directors authorized the repurchase of an additional $40 million of its Class A common stock. Stock repurchases under the program may be made periodically using a variety of methods, including without limitation, open market purchases, block trades or otherwise in compliance with all federal and state securities laws and state corporate law and in accordance with the single broker, timing, price, and volume guidelines set forth in Rule 10b-18 and Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, as such guidelines may be modified by the SEC from time to time. This stock repurchase program has no time limit and may be modified, suspended, or discontinued at any time. The Company currently intends to hold its repurchased shares as treasury stock.
As of December 31, 2023, the remaining amount of share repurchases under the program was $60.4 million. The following table summarizes share repurchases during the year ended December 31, 2023 and 2022.

Year ended December 31,
(in thousands, except per share data)20232022
Shares repurchased9,931 5,967 
Average price per share$4.03 $6.64 
Value of shares repurchased$40,000 $39,618 
    
Stock Repurchase Program, Remaining Authorized Repurchase Amount $ 60,400,000    
Stock Repurchase Program, Authorized Amount   $ 40 $ 100
v3.24.0.1
Compensation Related Costs, Share Based Payments (Policies)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Share-based Payment Arrangement
The income tax benefit related to stock-based compensation expense was $9.3 million, $8.6 million and $9.0 million for the year ended December 31, 2023, 2022, and 2021 respectively. See Note 8, Income taxes, for additional details.
As of December 31, 2023, total unearned stock-based compensation of $57.0 million related to stock options, RSUs, PSUs, and ESPP shares is expected to be recognized over a weighted-average period of 2.24 years.
v3.24.0.1
Summary of business and significant accounting policies (Tables)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of recent accounting pronouncements
Recent accounting standards
StandardDescriptionCompany’s date of adoption
Effect on the consolidated financial statements or other significant matters
Standards not yet adopted
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures
ASU No. 2023-07

This standard is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an interim and annual basis. Additionally, this standard would require that a public entity that has a single reportable segment provide all the disclosures required by the standard and all existing segment disclosures in Topic 280. This standard is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The standard requires retrospective application.
January 1, 2024
The Company is currently evaluating the impact of adopting this standard on its financial statements and related disclosures.
Income Taxes (Topic 740): Improvements to Income Tax Disclosures
ASU No. 2023-09
This standard requires reporting companies to break out income tax expense and a tax rate reconciliation in more detail. This standard is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The standard requires prospective transition with the option to apply retrospectively.
January 1, 2025
The Company is currently evaluating the impact of adopting this standard on its financial statements and related disclosures.
Although there are several other new accounting standards issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does not believe any of these accounting pronouncements has had or will have a material impact on its consolidated financial statements.
v3.24.0.1
Fair value measurements (Tables)
 12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Assets measured at fair value on recurring basis
The Company’s assets that are measured at fair value on a recurring basis within the fair value hierarchy are summarized as follows:
December 31, 2023December 31, 2022
(in thousands)Level 1Level 2TotalLevel 1Level 2Total
Cash equivalents (1):
Money market funds$152,760 $— $152,760 $138,394 $— $138,394 
Total cash equivalents$152,760 $— $152,760 $138,394 $— $138,394 
Marketable securities:
U.S. treasury securities$— $7,962 $7,962 $— $14,716 $14,716 
Commercial paper— 7,942 7,942 — 87,436 87,436 
Corporate debt securities— 3,978 3,978 — 29,637 29,637 
Government securities— 3,985 3,985 — 11,813 11,813 
Total marketable securities$— $23,867 $23,867 $— $143,602 $143,602 
(1)    Included in cash and cash equivalents in the accompanying Consolidated Balance Sheets. Cash balances were $69.9 million and $85.3 million as of December 31, 2023 and 2022, respectively.
v3.24.0.1
Condensed consolidated financial statement details (Tables)
 12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Inventory
Inventory
(in thousands)
December 31, 2023December 31, 2022
Components
$20,311 $38,400 
Finished goods
85,955 88,731 
Total inventory
$106,266 $127,131 
Property, Plant and Equipment
Property and equipment, net
(in thousands)
Useful life
(in years)		December 31, 2023December 31, 2022
Leasehold improvements1–9$23,818 $32,472 
Production, engineering, and other equipment438,574 46,475 
Tooling1–25,678 9,033 
Computers and software213,896 17,258 
Furniture and office equipment34,575 4,879 
Tradeshow equipment and other2–51,502 1,664 
Construction in progress83 59 
Gross property and equipment
88,126 111,840 
Less: Accumulated depreciation and amortization(79,440)(98,513)
Property and equipment, net
$8,686 $13,327 
Depreciation expense was $6.2 million, $8.5 million, and $9.8 million in 2023, 2022, and 2021, respectively. In 2022, the Company recorded accelerated depreciation charges in connection with its plans to vacate certain manufacturing facilities as disclosed in Note 11 Restructuring charges.
Schedule of Other Assets
(in thousands)
December 31, 2023December 31, 2022
Long-term deferred tax assets
$296,984 $279,045 
Deposits and other
8,233 8,435 
Point of purchase (POP) displays
6,254 1,798 
Intangible assets, net15 15 
Other long-term assets$311,486 $289,293 
Intangible assets are comprised of purchased technology, which had a useful life between 20-72 months, and an indefinite life asset. Amortization expense was zero, $0.1 million, and $1.2 million in 2023, 2022, and 2021, respectively. As of December 31, 2023, and 2022, all of the Company’s purchased technology intangible assets were fully amortized.
Amortization expense for POP displays was $2.0 million, $2.1 million, and $2.8 million in 2023, 2022, and 2021, respectively.
Schedule of Accrued Liabilities
Accrued expenses and other current liabilities
(in thousands)
December 31, 2023December 31, 2022
Accrued sales incentives$42,752 $41,662 
Accrued liabilities (1)
21,214 35,853 
Employee related liabilities18,969 11,261 
Warranty liabilities8,270 7,825 
Return liability6,389 6,002 
Customer deposits
1,933 3,428 
Inventory received
1,745 233 
Purchase order commitments
899 782 
Other
7,878 11,831 
Accrued expenses and other current liabilities$110,049 $118,877 
Schedule of Product Warranty Liability
Product warranty
Year ended December 31,
(in thousands)
202320222021
Beginning balance
$8,319 $8,842 $8,523 
Charged to cost of revenue
19,724 18,573 16,641 
Settlement of warranty claims
(19,284)(19,096)(16,322)
Warranty liability
$8,759 $8,319 $8,842 
At December 31, 2023 and 2022, $8.3 million and $7.8 million, respectively, of the warranty liability was recorded as a component of accrued expenses and other current liabilities, and $0.5 million and $0.5 million, respectively, was recorded as a component of other long-term liabilities.
v3.24.0.1
Employee benefit plans (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
schedule of share-based compensation, Performance Stock Units Award Activity [Table Text Block]
A summary of the Company’s PSU activity is as follows:
Shares
(in thousands)
Weighted-average grant date fair value
Non-vested shares at December 31, 2022686 

$7.93 
Granted1,254 5.79 
Vested(485)7.71 
Forfeited(631)5.86 
Non-vested shares at December 31, 2023824 $6.38 
Schedule of Share-based Compensation, Stock Options, Activity
A summary of the Company’s stock option activity is as follows:
Shares
(in thousands)
Weighted-average exercise price
Weighted-average remaining contractual term (in years)
Aggregate intrinsic value (in thousands)
Outstanding at December 31, 20223,089 $9.37 5.30$467 
Granted198 3.58 
Exercised— — 
Forfeited/Cancelled(603)11.64 
Outstanding at December 31, 20232,684 $8.43 5.08$— 
Vested and expected to vest at December 31, 20232,684 $8.43 5.08$— 
Exercisable at December 31, 20232,250 $8.92 4.40$— 
Schedule of Share-based Compensation, Restricted Stock Units Award Activity
A summary of the Company’s RSU activity is as follows:
Shares
(in thousands)
Weighted-average grant date fair value
Non-vested shares at December 31, 20228,727 $7.19 
Granted8,595 5.13 
Vested(5,224)6.61 
Forfeited(604)6.68 
Non-vested shares at December 31, 202311,494 $5.94 
Allocation of Stock-based Compensation Expense The following table summarizes stock-based compensation expense included in the Consolidated Statements of Operations:
Year ended December 31,
(in thousands)
202320222021
Cost of revenue
$1,955 $1,805 $1,794 
Research and development
19,062 17,221 17,263 
Sales and marketing
8,736 8,173 8,045 
General and administrative
11,726 11,792 11,548 
Total stock-based compensation expense$41,479 $38,991 $38,650 
Class of Treasury Stock
Year ended December 31,
(in thousands, except per share data)20232022
Shares repurchased9,931 5,967 
Average price per share$4.03 $6.64 
Value of shares repurchased$40,000 $39,618 
v3.24.0.1
Net loss per share (Tables)
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Net Income per Share, Basic and Diluted
7. Net income (loss) per share
The following table presents the calculations of basic and diluted net income (loss) per share:
Year ended December 31,
(in thousands, except per share data)202320222021
Numerator:
Net income (loss) - Basic$(53,183)$28,847 $371,171 
Interest on convertible notes, income tax effected— 3,055 — 
Net income (loss) - Diluted$(53,183)$31,902 $371,171 
Denominator:
Weighted-average common shares - basic for Class A and Class B common stock153,348 156,181 154,274 
Effect of dilutive securities— 22,098 8,904 
Weighted-average common shares - diluted for Class A and Class B common stock153,348 178,279 163,178 
Net income (loss) per share
Basic$(0.35)$0.18 $2.41 
Diluted$(0.35)$0.18 $2.27 
Schedule of Antidilutive Securities Excluded from Computation of Net Income per Share
The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:
Year ended December 31,
(in thousands)
202320222021
Stock-based awards15,839 7,495 1,792 
Shares related to convertible senior notes14,808 — — 
Total anti-dilutive securities30,647 7,495 1,792 
v3.24.0.1
Income taxes (Tables)
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
Income tax expense (benefit) consisted of the following:
Year ended December 31,
(in thousands)
202320222021
Current
Federal$3 $2 $(128)
State162 818 267 
Foreign3,176 2,076 (7,669)
Total current3,341 2,896 (7,530)
Deferred
Federal(14,018)5,039 (205,856)
State(3,828)(2,312)(67,933)
Foreign(45)(17)248 
Total deferred(17,891)2,710 (273,541)
Income tax expense (benefit)$(14,550)$5,606 $(281,071)
v3.24.0.1
Commitments, contingencies and guarantees (Tables)
 12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Components of Lease Expense [Text Block]
The components of net lease cost, which were primarily recorded in operating expenses, were as follows:
Year ended December 31,
(in thousands)202320222021
Operating lease cost (1)
$11,045 $11,060 $11,566 
Sublease income(2,281)(2,907)(964)
Net lease cost$8,764 $8,153 $10,602 
(1)    Operating lease cost includes variable lease costs, which are immaterial.

Supplemental cash flow information related to leases was as follows:
Year ended December 31,
(in thousands)202320222021
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases$12,217 $14,595 $14,902 
Right-of-use assets obtained in exchange for operating lease liabilities3,943 1,221 2,475 
Operating lease modification to decrease right-of-use assets— (232)— 

Supplemental balance sheet information related to leases was as follows:
December 31, 2023December 31, 2022
Weighted-average remaining lease term (in years) - operating leases3.053.81
Weighted-average discount rate - operating leases6.2%6.1%
Schedule of Maturities of Lease Liabilities [Text Block]
As of December 31, 2023, maturities of operating lease liabilities were as follows:
(in thousands)
December 31, 2023
2024$12,488 
202513,141 
202612,361 
20271,359 
2028401 
Thereafter103 
Total lease payments39,853 
Less: Imputed interest(3,806)
Present value of lease liabilities$36,047 
v3.24.0.1
Concentrations of risk and geographic information (Tables)
 12 Months Ended
Dec. 31, 2023
Concentration Risk [Line Items]  
Schedule of Accounts, Notes, Loans and Financing Receivable
The following table summarizes the Company’s accounts receivables sold, without recourse, and factoring fees paid:
Year ended December 31,
(in thousands)
202320222021
Accounts receivable sold$103,990 $124,350 $108,625 
Factoring fees1,555 1,163 488 
Schedule of Revenue by Geographic Region
Revenue by geographic region, based on ship-to locations, was as follows:
Year ended December 31,2023 vs 20222022 vs 2021
(in thousands)
202320222021
% Change
% Change
Americas
$469,675 $521,270 $607,534 (10)%(14)%
Europe, Middle East and Africa (EMEA)290,814 300,870 305,654 (3)(2)
Asia and Pacific (APAC)
244,970 271,401 247,896 (10)9 
Total revenue
$1,005,459 $1,093,541 $1,161,084 (8)%(6)%
Accounts Receivable [Member]  
Concentration Risk [Line Items]  
Schedules of Customer Concentration by Risk Factor
Customers who represented 10% or more of the Company’s net accounts receivable balance were as follows:
December 31, 2023December 31, 2022
Customer A30%30%
Customer B11%11%
Sales Revenue [Member]  
Concentration Risk [Line Items]  
Schedules of Customer Concentration by Risk Factor
Third-party customers who represented 10% or more of the Company's total revenue were as follows:
Year ended December 31,
202320222021
Customer A**11%
* Less than 10% of total revenue for the periods indicated.
v3.24.0.1
Summary of business and significant accounting policies (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Jan. 01, 2022
Nov. 24, 2020
Apr. 12, 2017
Property, Plant and Equipment [Line Items]              
Allowance for Doubtful Other Receivables, Current $ 500 $ 500 $ 400        
Contract with Customer, Liability 59,100 59,100 60,400        
Deferred Revenue, Revenue Recognized   57,200 43,100        
Advertising Expense   44,100 40,800 $ 35,800      
Accumulated deficit (249,296) $ (249,296) (196,113)   $ 47,100    
Product Warranty Liability [Line Items]              
Warranty Period   12 months          
Gain (Loss) on Extinguishment of Debt 3,100 $ 3,092 0 0      
Gain (Loss) on Extinguishment of Debt $ 3,100 $ 3,092 $ 0 $ 0      
Convertible Senior Notes due 2022 [Member]              
Property, Plant and Equipment [Line Items]              
Interest rate             3.50%
Debt Instrument             $ 175,000
Convertible Senior Notes due 2025 [Member]              
Property, Plant and Equipment [Line Items]              
Interest rate           1.25%  
Debt Instrument           $ 143,800  
Europe [Member]              
Product Warranty Liability [Line Items]              
Warranty Period   24 months          
v3.24.0.1
Fair value measurements (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Nov. 24, 2020
Apr. 12, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash $ 69,900 $ 85,300    
Marketable securities 23,867 143,602    
Repayments of Convertible Debt 50,000      
Fair Value, Recurring [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash and Cash Equivalents 152,760 138,394    
Marketable securities 23,867 143,602    
Fair Value, Recurring [Member] | Money Market Funds [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash and Cash Equivalents 152,760 138,394    
Fair Value, Recurring [Member] | Level 1 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash and Cash Equivalents 152,760 138,394    
Marketable securities 0 0    
Fair Value, Recurring [Member] | Level 1 [Member] | Money Market Funds [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash and Cash Equivalents 152,760 138,394    
Fair Value, Recurring [Member] | Level 2 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash and Cash Equivalents 0 0    
Marketable securities 23,867 143,602    
Fair Value, Recurring [Member] | Level 2 [Member] | Money Market Funds [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash and Cash Equivalents 0 0    
Convertible Senior Notes due 2022 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Debt Instrument       $ 175,000
Convertible Senior Notes due 2025 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Debt Instrument     $ 143,800  
Convertible Senior Notes due 2025 [Member] | Level 2 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Fair value of convertible senior notes 82,300 130,100    
Corporate Debt Securities [Member] | Fair Value, Recurring [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 3,978 29,637    
Corporate Debt Securities [Member] | Fair Value, Recurring [Member] | Level 1 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 0 0    
Corporate Debt Securities [Member] | Fair Value, Recurring [Member] | Level 2 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 3,978 29,637    
Commercial Paper | Fair Value, Recurring [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 7,942 87,436    
Commercial Paper | Fair Value, Recurring [Member] | Level 1 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 0 0    
Commercial Paper | Fair Value, Recurring [Member] | Level 2 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 7,942 87,436    
US Government Debt Securities [Member] | Fair Value, Recurring [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 3,985 11,813    
US Government Debt Securities [Member] | Fair Value, Recurring [Member] | Level 1 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 0 0    
US Government Debt Securities [Member] | Fair Value, Recurring [Member] | Level 2 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 3,985 11,813    
US Treasury Securities | Fair Value, Recurring [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 7,962 14,716    
US Treasury Securities | Fair Value, Recurring [Member] | Level 1 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 0 0    
US Treasury Securities | Fair Value, Recurring [Member] | Level 2 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities $ 7,962 $ 14,716    
v3.24.0.1
Condensed consolidated financial statement details - Cash, Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Cash and Cash Equivalents [Line Items]    
Cash $ 69,900 $ 85,300
Cash and cash equivalents $ 222,708 $ 223,735
v3.24.0.1
Condensed consolidated financial statement details - Inventory (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Components $ 20,311 $ 38,400
Finished goods 85,955 88,731
Total inventory $ 106,266 $ 127,131
v3.24.0.1
Condensed consolidated financial statement details - Property and Equipment, Net (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]      
Gross property and equipment $ 88,126 $ 111,840  
Less: Accumulated depreciation and amortization (79,440) (98,513)  
Property and equipment, net 8,686 13,327  
Depreciation 6,200 8,500 $ 9,800
Leasehold Improvements [Member]      
Property, Plant and Equipment [Line Items]      
Gross property and equipment 23,818 32,472  
Production, engineering and other equipment [Member]      
Property, Plant and Equipment [Line Items]      
Gross property and equipment 38,574 46,475  
Tooling [Member]      
Property, Plant and Equipment [Line Items]      
Gross property and equipment 5,678 9,033  
Computers and software [Member]      
Property, Plant and Equipment [Line Items]      
Gross property and equipment 13,896 17,258  
Furniture and office equipment [Member]      
Property, Plant and Equipment [Line Items]      
Gross property and equipment 4,575 4,879  
Tradeshow Equipment and other [Member]      
Property, Plant and Equipment [Line Items]      
Gross property and equipment 1,502 1,664  
Construction in Progress [Member]      
Property, Plant and Equipment [Line Items]      
Gross property and equipment $ 83 $ 59  
v3.24.0.1
Condensed consolidated financial statement details - Intangible Assets and Goodwill (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets, Net [Abstract]      
Intangible assets, net $ 15 $ 15  
Indefinite-lived Intangible Assets [Roll Forward]      
Amortization of intangible assets 0 100 $ 1,200
Goodwill $ 146,459 $ 146,459  
v3.24.0.1
Condensed consolidated financial statement details - Goodwill (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Goodwill $ 146,459 $ 146,459
v3.24.0.1
Condensed consolidated financial statement details - Other Assets (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
POP Displays $ 6,254 $ 1,798  
Deposits and other 8,233 8,435  
Other long-term assets 311,486 289,293  
Amortization of intangible assets 0 100 $ 1,200
Amortization 2,000 2,100 2,800
Intangible Assets, Net (Excluding Goodwill) 15 15  
Deferred Income Tax Assets, Net $ 296,984   $ 279,040
Long-term deferred tax assets   $ 279,045  
v3.24.0.1
Condensed consolidated financial statement details - Product Warranty (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Beginning balances $ 8,319 $ 8,842 $ 8,523
Charged to cost of revenue 19,724 18,573 16,641
Settlements of warranty claims (19,284) (19,096) (16,322)
Ending balances 8,759 8,319 $ 8,842
Product Warranty Accrual, Noncurrent 500 500  
Product Warranty Accrual, Current $ 8,270 $ 7,825  
v3.24.0.1
Condensed consolidated financial statement details - Accrued Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Product Warranty Accrual, Current $ 8,270 $ 7,825
Employee related liabilities 18,969 11,261
Accrued sales incentives 42,752 41,662
Other Accounts Payable and Accrued Liabilities 21,214 35,853
Customer Refund Liability, Current 6,389 6,002
Customer deposits 1,933 3,428
Purchase Commitment, Remaining Minimum Amount Committed 899 782
Inventory received 1,745 233
Other 7,878 11,831
Accrued expenses and other current liabilities $ 110,049 $ 118,877
v3.24.0.1
Financing Arrangements (Details)
 3 Months Ended 12 Months Ended
Jan. 21, 2021
USD ($)
Nov. 24, 2020
USD ($)
$ / shares
Dec. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Jan. 01, 2022
USD ($)
Jan. 22, 2021
USD ($)
Apr. 12, 2017
USD ($)
$ / shares
Line of Credit Facility [Line Items]                  
Long-term debt     $ 92,615,000 $ 92,615,000 $ 141,017,000        
Amortization of Debt Discount (Premium)       $ 0 0 $ 14,208,000      
Debt Instrument, Covenant Compliance, Asset Coverage Ratio     1.50 1.50          
Adjustments to Additional Paid in Capital, Capped Call Option, Issuance Costs   $ (10,200,000)              
Option Indexed To Issuers Equity, cap price   12.0925              
Payments to repurchase convertible debt   50,000,000              
Interest Paid, Including Capitalized Interest, Operating and Investing Activities       $ 1,976,000 4,258,000 6,127,000      
Gain (Loss) on Extinguishment of Debt     $ 3,100,000 3,092,000 $ 0 0      
Debt Instrument, Repurchase Amount     46,300,000 46,300,000          
Debt Instrument, Repurchased Face Amount     49,400,000 49,400,000          
Letters of Credit Outstanding, Amount     5,200,000 5,200,000          
Debt Instrument, Periodic Payment, Interest       2,200,000          
Convertible Senior Notes due 2022 [Member]                  
Line of Credit Facility [Line Items]                  
Effective rate         1.20%        
Amortization of Debt Discount (Premium)       0 $ 0 7,800,000      
Repayments of Debt       125,000,000          
Convertible Senior Notes due 2025 [Member]                  
Line of Credit Facility [Line Items]                  
Amortization of Debt Discount (Premium)       0 0 6,400,000      
Convertible Senior Notes due 2025 [Member] | Private Placement [Member]                  
Line of Credit Facility [Line Items]                  
Debt Instrument   125,000,000              
2021 Credit Facility [Member]                  
Line of Credit Facility [Line Items]                  
Credit agreement, current borrowing capacity               $ 50,000,000  
Minimum Fixed Charge Coverage Ratio, minimum balance $ 10,000,000                
Line of Credit Facility, Unused Capacity, Minimum Liquidity Requirement, Amount 55,000,000                
Line of Credit Facility, Unused Capacity, Qualified Cash $ 40,000,000                
Convertible Senior Notes due 2022 [Member]                  
Line of Credit Facility [Line Items]                  
Debt Instrument                 $ 175,000,000
Long-term Debt, Percentage Bearing Fixed Interest, Amount             $ 2,300,000   $ 128,300,000
Interest rate                 3.50%
Debt Instrument, Convertible, Conversion Price | $ / shares                 $ 10.64
Convertible debt, equity portion                 $ 46,700,000
Effective rate                 10.50%
Debt Issuance Costs, Net                 $ 5,700,000
Interest Expense, Debt       0 1,300,000 4,400,000      
Amortization of Debt Issuance Costs       0 200,000 600,000      
Debt Instrument, Repurchase Amount   56,200,000              
Convertible Senior Notes due 2022 [Member] | Long-term Debt [Member]                  
Line of Credit Facility [Line Items]                  
Debt Issuance Costs, Gross                 4,200,000
Convertible Senior Notes due 2022 [Member] | Additional Paid-in Capital [Member]                  
Line of Credit Facility [Line Items]                  
Debt Issuance Costs, Gross                 $ 1,500,000
Convertible Senior Notes due 2025 [Member]                  
Line of Credit Facility [Line Items]                  
Debt Instrument   143,800,000              
Long-term Debt, Percentage Bearing Fixed Interest, Amount   $ 106,900,000         $ 28,800,000    
Interest rate   1.25%              
Debt Instrument, Convertible, Conversion Ratio   107.1984              
Convertible Debt Principal Amount Conversion   $ 1,000 $ 93,800,000 $ 93,800,000 $ 143,800,000        
Debt Instrument, Convertible, Conversion Price | $ / shares   $ 9.3285              
Convertible debt, equity portion   $ 36,900,000              
Effective rate   7.50% 2.80% 2.80% 1.90%        
Debt Issuance Costs, Net   $ 4,700,000              
Percentage of conversion price of notes     130.00%            
Percentage of trading price of notes     98.00%            
Long-term debt     $ 92,600,000 $ 92,600,000 $ 141,000,000        
Interest Expense, Debt       1,700,000 1,800,000 1,800,000      
Amortization of Debt Issuance Costs       900,000 1,000,000 $ 700,000      
Convertible Senior Notes due 2025 [Member] | Long-term Debt [Member]                  
Line of Credit Facility [Line Items]                  
Debt Issuance Costs, Gross   3,500,000              
Debt Issuance Costs, Net     $ 1,200,000 $ 1,200,000 $ 2,800,000        
Convertible Senior Notes due 2025 [Member] | Additional Paid-in Capital [Member]                  
Line of Credit Facility [Line Items]                  
Debt Issuance Costs, Gross   1,200,000              
Convertible Senior Notes due 2025 [Member] | Over-Allotment Option [Member]                  
Line of Credit Facility [Line Items]                  
Debt Instrument   $ 18,800,000              
Base Rate [Member] | Minimum [Member] | 2021 Credit Facility [Member]                  
Line of Credit Facility [Line Items]                  
Basis Spread on Variable Rate 0.50%                
Base Rate [Member] | Maximum [Member] | 2021 Credit Facility [Member]                  
Line of Credit Facility [Line Items]                  
Basis Spread on Variable Rate 1.00%                
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Minimum [Member] | 2021 Credit Facility [Member]                  
Line of Credit Facility [Line Items]                  
Basis Spread on Variable Rate 1.50%                
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Maximum [Member] | 2021 Credit Facility [Member]                  
Line of Credit Facility [Line Items]                  
Basis Spread on Variable Rate 2.00%                
v3.24.0.1
Stockholders' equity (Details)
 12 Months Ended
Dec. 31, 2023
USD ($)
shares
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Feb. 09, 2023
USD ($)
Jan. 27, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Class of Stock [Line Items]            
Stock options outstanding (shares) 2,684,000 3,089,000        
Common stock available for future grants (shares) 53,033,000          
Stockholders' Equity Note, Outstanding Shares Less than 10% of Aggregate Shares Outstanding, Conversion Ratio 1          
Stockholders' Equity Attributable to Parent | $ $ 555,846,000 $ 611,559,000     $ 615,914,000 $ 216,018,000
Stock Repurchase Program, Authorized Amount | $     $ 40 $ 100    
Stock Repurchase Program, Remaining Authorized Repurchase Amount | $ $ 60,400,000          
Treasury Stock, Shares, Acquired 9,931 5,967        
Treasury Stock Acquired, Average Cost Per Share | $ / shares $ 4.03 $ 6.64        
Stock Repurchased During Period, Value | $ $ 40,000,000 $ 39,618,000        
Treasury Stock, Value, Acquired, Cost Method | $ 40,000,000 39,618,000        
Treasury Stock, Common            
Class of Stock [Line Items]            
Stockholders' Equity Attributable to Parent | $ $ (193,231,000) $ (153,231,000)     $ (113,613,000) $ (113,613,000)
Common Class A [Member]            
Class of Stock [Line Items]            
Common stock authorized (shares) 500,000,000 500,000,000        
Common stock outstanding (shares) 123,638,000 128,629,000        
Common Stock, Voting Rights, Number 1          
Common Stock, Conversion Ratio 1          
Common Stock, Shares, Issued 123,638,000 128,629,000        
Common Stock, Voting Rights one          
Common Class B [Member]            
Class of Stock [Line Items]            
Common stock authorized (shares) 150,000,000 150,000,000        
Common stock outstanding (shares) 26,259,000 26,259,000        
Common Stock, Voting Rights, Number 10          
Common Stock, Shares, Issued 26,259,000 26,259,000        
Common Stock, Voting Rights ten          
Restricted Stock Units (RSUs) [Member]            
Class of Stock [Line Items]            
Restricted stock units outstanding (shares) 11,494,000 8,727,000        
Performance Shares [Member]            
Class of Stock [Line Items]            
Restricted stock units outstanding (shares) 824,000 686,000        
Performance stock units outstanding (shares) 1,441,000          
Common Stock            
Class of Stock [Line Items]            
Common stock available for future grants (shares) 37,414,000          
v3.24.0.1
Employee benefit plans - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
ESPP stock issued during period (shares) 900,000 700,000 800,000
ESPP weighted average purchase price of shares purchased (usd per share) $ 4.10 $ 6.72 $ 5.28
Unearned stock-based compensation, expected recognition period 2 years 2 months 26 days    
Share-based Payment Arrangement, Expense, Tax Benefit $ 9,300,000 $ 8,600,000 $ 9,000,000
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 100.00%    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value $ 1,400,000 1,500,000 1,500,000
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 100.00%    
Defined Benefit Plan, Plan Assets, Contributions by Employer $ 900,000 $ 800,000 $ 800,000
Stock Repurchased During Period, Shares 9,931,000 5,967,000  
Treasury Stock Acquired, Average Cost Per Share $ 4.03 $ 6.64  
Stock Repurchased During Period, Value $ 40,000,000 $ 39,618,000  
Defined Contribution Plan, Minimum Annual Contributions Per Employee, Percent 1    
RSUs [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted (shares) 8,595,000    
Weighted average price of shares granted (usd per share) $ 5.13 $ 7.68 $ 8.83
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 34,500,000 $ 30,800,000 $ 28,500,000
Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted (shares) 1,254,000    
Weighted average price of shares granted (usd per share) $ 5.79    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 3,700,000 4,800,000 3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value $ 5.79 $ 8.70 $ 7.93
Employee Stock Purchase Plan Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Purchase Price of Common Stock, Percent 85.00%    
Stock Options, ESPP and Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unearned stock-based compensation costs $ 57,000,000    
2014 Equity Incentive Plans [Member] | Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expiration Period 10 years    
2014 Equity Incentive Plans [Member] | Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award Vesting Period 3 years    
2014 Equity Incentive Plans [Member] | Minimum [Member] | Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award Vesting Period 1 year    
2014 Equity Incentive Plans [Member] | Minimum [Member] | RSUs [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award Vesting Period 2 years    
2014 Equity Incentive Plans [Member] | Maximum [Member] | Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award Vesting Period 4 years    
2014 Equity Incentive Plans [Member] | Maximum [Member] | RSUs [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award Vesting Period 4 years    
v3.24.0.1
Employee benefit plans - Stock Option Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Shares (in thousands)        
Outstanding at beginning of period (shares)   3,089    
Granted (shares)   198    
Exercised (shares)   0    
Forfeited/Cancelled (shares)   (603)    
Outstanding at end of period (shares) 3,089 2,684 3,089  
Weighted-average exercise price        
Outstanding at beginning of period (in dollars per share)   $ 9.37    
Granted (usd per share)   3.58    
Exercised (usd per share)   0    
Outstanding at end of period (in dollars per share) $ 9.37 $ 8.43 $ 9.37  
Aggregate intrinsic value (in thousands) $ 467,000 $ 0 $ 467,000  
Vested and Expected to Vest (shares)   2,684    
Vested and Expected to Vest - Weighted Average Exercise Price (in dollars per share)   $ 8.43    
Vested and Expected to Vest- Weighted Average Remaining Contractual Term   5 years 29 days    
Vested and Expected to Vest - Aggregate Intrinsic Value   $ 0    
Exercisable (shares)   2,250    
Exercisable - Weighted average exercise price (in dollars per share)   $ 8.92    
Exercisable - Weighted Average Remaining Contractual Term   4 years 4 months 24 days    
Exercisable - Aggregate intrinsic value   $ 0    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price   $ 11.64    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 2.14 $ 5.05 $ 4.62
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value   $ 1,400,000 $ 1,500,000 $ 1,500,000
Weighted Average Remaining Contractual Term (in years) 5 years 3 months 18 days 5 years 29 days    
v3.24.0.1
Employee benefit plans - Restricted Stock Units Activity (Details) - $ / shares
shares in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
RSUs [Member]      
Shares (in thousands)      
Non-vested shares at beginning of period (shares) 8,727    
Granted (shares) 8,595    
Vested (shares) (5,224)    
Forfeited (shares) (604)    
Non-vested shares at end of period (shares) 11,494 8,727  
Weighted-average grant date fair value      
Non-vested shares at beginning of period (in dollars per share) $ 7.19    
Weighted average price of shares granted (usd per share) 5.13 $ 7.68 $ 8.83
Weighted average price of shares vested (usd per share) 6.61    
Weighted average price of shares forfeited (usd per share) 6.68    
Non-vested shares at end of period (in dollars per share) $ 5.94 $ 7.19  
Performance Shares [Member]      
Shares (in thousands)      
Non-vested shares at beginning of period (shares) 686    
Granted (shares) 1,254    
Vested (shares) (485)    
Forfeited (shares) (631)    
Non-vested shares at end of period (shares) 824 686  
Weighted-average grant date fair value      
Non-vested shares at beginning of period (in dollars per share) $ 7.93    
Weighted average price of shares granted (usd per share) 5.79    
Weighted average price of shares vested (usd per share) 7.71    
Weighted average price of shares forfeited (usd per share) 5.86    
Non-vested shares at end of period (in dollars per share) $ 6.38 $ 7.93  
v3.24.0.1
Employee benefit plans - Fair Value Assumptions for Stock Options (Details)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected Term 6.10 6.10 6.10
Interest Rate, Minimum 5.00%    
Interest Rate, Maximum 5.60% 3.10%  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]      
Expected Term 6.10 6.10 6.10
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Expected Term 6.10 6.10 6.10
Equity Option [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility Rate, Minimum 59.00%    
Dividend yield 0.00% 0.00% 0.00%
Interest Rate, Minimum 3.50% 2.00% 0.70%
Interest Rate, Maximum 4.50% 3.90% 1.10%
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate   60.00% 64.00%
Volatility Rate, Maximum 60.00% 62.00%  
Dividend yield 0.00% 0.00% 0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate   60.00% 64.00%
Volatility Rate, Maximum 60.00% 62.00%  
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Volatility Rate, Minimum 59.00%    
Volatility Rate, Maximum 60.00% 62.00%  
Employee Stock Purchase Plan Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility Rate, Minimum 39.00% 39.00% 64.00%
Expected Term 0.5 0.5 0.5
Dividend yield 0.00% 0.00% 0.00%
Interest Rate, Minimum   0.70%  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]      
Expected Term 0.5 0.5 0.5
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Expected Term 0.5 0.5 0.5
Volatility Rate, Maximum 42.00% 55.00% 80.00%
Dividend yield 0.00% 0.00% 0.00%
Volatility Rate, Maximum 42.00% 55.00% 80.00%
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Volatility Rate, Minimum 39.00% 39.00% 64.00%
Volatility Rate, Maximum 42.00% 55.00% 80.00%
v3.24.0.1
Employee benefit plans - Fair Value Assumptions for Restricted Stock Units and ESPP (Details)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Interest Rate, Minimum 5.00%    
Interest Rate, Maximum 5.60% 3.10%  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Expected Term 6.10 6.10 6.10
Interest Rate, Maximum 5.60% 3.10%  
Employee Stock Purchase Plan Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility Rate, Minimum 39.00% 39.00% 64.00%
Dividend yield 0.00% 0.00% 0.00%
Volatility Rate, Maximum 42.00% 55.00% 80.00%
Interest Rate, Minimum   0.70%  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Expected Term 0.5 0.5 0.5
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate     0.10%
Dividend yield 0.00% 0.00% 0.00%
Equity Option [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility Rate, Minimum 59.00%    
Dividend yield 0.00% 0.00% 0.00%
Volatility Rate, Maximum 60.00% 62.00%  
Interest Rate, Minimum 3.50% 2.00% 0.70%
Interest Rate, Maximum 4.50% 3.90% 1.10%
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate   60.00% 64.00%
Interest Rate, Maximum 4.50% 3.90% 1.10%
Dividend yield 0.00% 0.00% 0.00%
v3.24.0.1
Employee benefit plans - Allocation of Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total stock-based compensation expense $ 41,479 $ 38,991 $ 38,650
Share-based Payment Arrangement, Expense, Tax Benefit $ 9,300 8,600 9,000
Unearned stock-based compensation, expected recognition period 2 years 2 months 26 days    
Cost of Revenue [Member]      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total stock-based compensation expense $ 1,955 1,805 1,794
Research and Development [Member]      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total stock-based compensation expense 19,062 17,221 17,263
Selling and Marketing Expense [Member]      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total stock-based compensation expense 8,736 8,173 8,045
General and Administrative [Member]      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Total stock-based compensation expense $ 11,726 $ 11,792 $ 11,548
v3.24.0.1
Employee benefit plans Performance Stock Units activity (Details) - USD ($)
$ / shares in Units, shares in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Restricted stock units outstanding (shares) 824 686  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 6.38 $ 7.93  
Granted (shares) 1,254    
Weighted average price of shares granted (usd per share) $ 5.79    
Vested (shares) (485)    
Weighted average price of shares vested (usd per share) $ 7.71    
Forfeited (shares) (631)    
Weighted average price of shares forfeited (usd per share) $ 5.86    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 3,700,000 $ 4,800,000 $ 3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 3,700,000 $ 4,800,000 $ 3,000,000
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Restricted stock units outstanding (shares) 11,494 8,727  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 5.94 $ 7.19  
Granted (shares) 8,595    
Weighted average price of shares granted (usd per share) $ 5.13 $ 7.68 $ 8.83
Vested (shares) (5,224)    
Weighted average price of shares vested (usd per share) $ 6.61    
Forfeited (shares) (604)    
Weighted average price of shares forfeited (usd per share) $ 6.68    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 34,500,000 $ 30,800,000 $ 28,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 34,500,000 $ 30,800,000 $ 28,500,000
v3.24.0.1
Net loss per share Additional Information (Details)
 12 Months Ended
Dec. 31, 2023
shares
Nov. 24, 2020
USD ($)
$ / shares
Apr. 12, 2017
USD ($)
$ / shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Conversion of Stock maxium percent of outstanding shares in class of total outstanding shares 10.00%    
Option Indexed To Issuers Equity, cap price | $   $ 12.0925  
Conversion of Stock maxium percent of outstanding shares in class of total outstanding shares 10.00%    
Common Class A [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Common Stock, Voting Rights, Number | shares 1    
Conversion of Stock, Shares Issued | shares 1    
Common Class B [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Common Stock, Voting Rights, Number | shares 10    
Convertible Senior Notes due 2022 [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Debt Instrument | $     $ 175,000,000
Interest rate     3.50%
Debt Instrument, Convertible, Conversion Price | $ / shares     $ 10.64
Convertible Senior Notes due 2025 [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Debt Instrument | $   $ 143,800,000  
Interest rate   1.25%  
Debt Instrument, Convertible, Conversion Price | $ / shares   $ 9.3285  
v3.24.0.1
Net loss per share - Basic and Diluted Net Income per Share Attributable to Common Stockholders (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Numerator:      
Net income (loss) $ (53,183) $ 28,847 $ 371,171
Interest on Convertible Debt, Net of Tax 0 3,055 0
Net Income (Loss) Attributable to Parent, Diluted $ (53,183) $ 31,902 $ 371,171
Denominator:      
Weighted Average Number of Shares Outstanding, Basic 153,348 156,181 154,274
Weighted Average Number Diluted Shares Outstanding Adjustment 0 22,098 8,904
Earnings Per Share, Diluted $ (0.35) $ 0.18 $ 2.27
Weighted Average Number of Shares Outstanding, Diluted 153,348 178,279 163,178
v3.24.0.1
Net loss per share - Antidilutive Securities Excluded from Computation of Net Income per Share (Details) - shares
shares in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Earnings Per Share [Abstract]      
Antidilutive securities excluded from computation of earnings per share (shares) 30,647 7,495 1,792
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (shares) 30,647 7,495 1,792
Convertible Debt Securities      
Earnings Per Share [Abstract]      
Antidilutive securities excluded from computation of earnings per share (shares) 14,808 0 0
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (shares) 14,808 0 0
Share-based Payment Arrangement      
Earnings Per Share [Abstract]      
Antidilutive securities excluded from computation of earnings per share (shares) 15,839 7,495 1,792
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (shares) 15,839 7,495 1,792
v3.24.0.1
Income taxes - Income Tax Expense (Details) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]        
Income tax (benefit) expense   $ (14,550,000) $ 5,606,000 $ (281,071,000)
Effective tax rate 16.30% 21.50% 16.30% (312.00%)
Current Federal Tax Expense (Benefit)   $ 3,000 $ 2,000 $ (128,000)
Current State and Local Tax Expense (Benefit)   162,000 818,000 267,000
Current Foreign Tax Expense (Benefit)   3,176,000 2,076,000 (7,669,000)
Current Income Tax Expense (Benefit)   3,341,000 2,896,000 (7,530,000)
Deferred Federal Income Tax Expense (Benefit)   (14,018,000) 5,039,000 (205,856,000)
Deferred State and Local Income Tax Expense (Benefit)   (3,828,000) (2,312,000) (67,933,000)
Deferred Foreign Income Tax Expense (Benefit)   (45,000) (17,000) 248,000
Deferred Income Tax Expense (Benefit)   (17,891,000) 2,710,000 (273,541,000)
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions   2,526,000 459,000 13,122,000
Stock-based compensation   $ 3,434,000 $ (1,192,000) $ (5,345,000)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent   (0.80%) 5.20% 1.90%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount   $ 557,000 $ 1,805,000 $ 1,684,000
v3.24.0.1
Income taxes - Narrative (Details) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating Loss Carryforwards [Line Items]          
Deferred Tax Assets, Operating Loss Carryforwards, Domestic   $ 394,100,000      
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions   4,948,000 $ 2,543,000 $ 3,081,000  
Income (Loss) from Continuing Operations before Income Taxes, Domestic   (79,514,000) 26,215,000 83,419,000  
Income tax (benefit) expense   (14,550,000) 5,606,000 (281,071,000)  
Loss before income taxes   $ (67,733,000) $ 34,453,000 $ 90,100,000  
Effective tax rate 16.30% 21.50% 16.30% (312.00%)  
Current Foreign Tax Expense (Benefit)   $ 3,176,000 $ 2,076,000 $ (7,669,000)  
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions   4,948,000 2,543,000 3,081,000  
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions   0 0 3,900,000  
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions   (2,526,000) (459,000) (13,122,000)  
Unrecognized Tax Benefits   25,836,000 23,414,000 21,330,000 $ 27,471,000
Accruals and reserves   20,540,000 22,001,000    
Total deferred tax assets   301,305,000 284,112,000    
Unrecognized Tax Benefits that Would Impact Effective Tax Rate   10,900,000 9,800,000 7,300,000  
Income (Loss) from Continuing Operations before Income Taxes, Foreign   11,781,000 8,238,000 $ 6,681,000  
Net operating loss carryforwards   109,059,000 118,399,000    
Tax credit carryforwards   96,610,000 91,147,000    
Stock-based compensation   5,966,000 6,034,000    
Allowance for returns   1,823,000 1,818,000    
Intangible assets   2,727,000 3,753,000    
Deferred Tax Assets, Operating Loss Carryforwards, Domestic   394,100,000      
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit   2,900,000      
Deferred Tax Assets, Property, Plant and Equipment   988,000 1,661,000    
Deferred Tax Liabilities, Other   4,321,000 5,072,000    
Deferred Tax Liabilities, Gross, Total   4,321,000 5,072,000    
Capitalized research and development costs   55,266,000 $ 29,122,000    
Domestic Tax Authority [Member]          
Operating Loss Carryforwards [Line Items]          
Tax Credit Carryforward, Amount   54,400,000      
Tax Credit Carryforward, Amount   54,400,000      
california [Domain]          
Operating Loss Carryforwards [Line Items]          
Tax Credit Carryforward, Amount   53,400,000      
Tax Credit Carryforward, Amount   53,400,000      
california [Domain]          
Operating Loss Carryforwards [Line Items]          
Deferred Tax Assets, Operating Loss Carryforwards, State and Local   243,100,000      
Deferred Tax Assets, Operating Loss Carryforwards, State and Local   243,100,000      
States Other than CA [Domain]          
Operating Loss Carryforwards [Line Items]          
Deferred Tax Assets, Operating Loss Carryforwards, State and Local   169,800,000      
Deferred Tax Assets, Operating Loss Carryforwards, State and Local   $ 169,800,000      
v3.24.0.1
Income taxes - Deferred Tax Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets:      
Net operating loss carryforwards $ 109,059 $ 118,399  
Tax credit carryforwards 96,610 91,147  
Stock-based compensation 5,966 6,034  
Allowance for returns 1,823 1,818  
Intangible assets 2,727 3,753  
Deferred Tax Assets, Operating lease liabilities 8,326 10,177  
Deferred Tax Assets, Property, Plant and Equipment 988 1,661  
Accruals and reserves 20,540 22,001  
Total deferred tax assets 301,305 284,112  
Deferred Tax Liabilities Operating Lease Liability (4,321) (5,072)  
Deferred Tax Liabilities, Gross, Total 4,321 $ 5,072  
Deferred Tax Assets, Net, Total $ 296,984   $ 279,040
v3.24.0.1
Income taxes - Reconciliation (Details) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]        
Tax at federal statutory rate   $ (14,224,000) $ 7,234,000 $ 18,921,000
Tax at federal statutory rate   21.00% 21.00% 21.00%
Change in valuation allowance   $ 0 $ 0 $ (284,551,000)
Change in valuation allowance   0.00% 0.00% (315.80%)
Impact of foreign operations   $ 2,969,000 $ 1,572,000 $ (8,222,000)
Impact of foreign operations   (4.40%) 4.60% (9.20%)
Stock-based compensation   $ 3,434,000 $ (1,192,000) $ (5,345,000)
Stock-based compensation   5.10% 3.50% 5.90%
State taxes, net of federal benefits   $ (1,560,000) $ 1,189,000 $ 1,828,000
State taxes, net of federal benefits   2.30% 3.50% 2.00%
Effective Income Tax Rate Reconciliation, Tax Credit, Amount   $ 5,474,000 $ 5,222,000 $ 6,091,000
Effective Income Tax Rate Reconciliation, Tax Credit, Percent   (8.10%) 15.10% 6.80%
Other   $ (252,000) $ 220,000 $ 705,000
Other   0.40% 0.60% 0.80%
Income tax (benefit) expense   $ (14,550,000) $ 5,606,000 $ (281,071,000)
Effective tax rate 16.30% 21.50% 16.30% (312.00%)
v3.24.0.1
Commitments, contingencies and guarantees (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Long-term Purchase Commitment [Line Items]      
Operating Lease, Cost $ 11,045 $ 11,060 $ 11,566
Operating Lease, Payments 12,217 14,595 14,902
Finance Lease, Liability, to be Paid, Year One 12,488    
Finance Lease, Liability, to be Paid, Year Two 13,141    
Finance Lease, Liability, to be Paid, Year Three 12,361    
Finance Lease, Liability, to be Paid, Year Four 1,359    
Finance Lease, Liability, to be Paid, Year Five 401    
Lessee, Operating Lease, Liability, Payments, Due after Year Five 103    
Lessee, Operating Lease, Liability, Payments, Due (39,853)    
us-gaap_Lessee Operating Lease Liability Undiscounted Excess Amount (3,806)    
Operating Lease, Liability 36,047    
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3,943 1,221 2,475
LesseeOperatingLeaseModification $ 0 $ (232) 0
Operating Lease, Weighted Average Remaining Lease Term 3 years 18 days 3 years 9 months 21 days  
Operating Lease, Weighted Average Discount Rate, Percent 6.20% 6.10%  
Sublease Income $ (2,281) $ (2,907) (964)
Lease, Cost 8,764 $ 8,153 $ 10,602
Other Commitments [Line Items]      
Other Commitment, to be Paid, Year One 36,045    
Other Commitment, to be Paid, Year Two 10,278    
Other Commitment, to be Paid, Year Three 4,673    
Other Commitment, to be Paid, Year Four 0    
Other Commitment, to be Paid, Year Five 0    
Long-Term Debt, Maturity, Year Five 0    
Long-Term Debt, Maturity, Year Four 0    
Long-Term Debt, Maturity, Year Three 0    
Long-Term Debt, Maturity, Year Two 94,922    
Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months 1,159    
Other Commitment 50,996    
Long-term Debt, Gross 96,081    
Contractual Obligation 147,077    
Contractual Obligation, to be Paid, Year One 37,204    
Contractual Obligation, to be Paid, Year Two 105,200    
Contractual Obligation, to be Paid, Year Three 4,673    
Contractual Obligation, to be Paid, Year Four 0    
Contractual Obligation, to be Paid, Year Five $ 0    
v3.24.0.1
Concentrations of risk and geographic information - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenue, Major Customer [Line Items]      
Revenue $ 1,005,459 $ 1,093,541 $ 1,161,084
United States [Member]      
Revenue, Major Customer [Line Items]      
Revenue 388,000 446,000 $ 526,500
Outside the United States [Member]      
Revenue, Major Customer [Line Items]      
Assets, Noncurrent $ 1,600 $ 4,000  
v3.24.0.1
Concentrations of risk and geographic information - Schedule of Customer Concentration by Risk Factor (Details) - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Concentration Risk [Line Items]        
Accounts receivable sold   $ 103,990 $ 124,350 $ 108,625
Factoring fees   $ 1,555 $ 1,163 $ 488
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer A [Member]        
Concentration Risk [Line Items]        
Concentration risk 30.00% 30.00%    
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer B [Member]        
Concentration Risk [Line Items]        
Concentration risk 11.00% 11.00%    
Customer Concentration Risk [Member] | Sales Revenue [Member] | Customer A [Member]        
Concentration Risk [Line Items]        
Concentration risk       11.00%
v3.24.0.1
Concentrations of risk and geographic information - Schedule of Revenue by Geographic Segment (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]      
Revenue $ 1,005,459 $ 1,093,541 $ 1,161,084
United States [Member]      
Segment Reporting Information [Line Items]      
Revenue 388,000 446,000 526,500
Americas [Member]      
Segment Reporting Information [Line Items]      
Revenue 469,675 521,270 607,534
Europe, Middle East and Africa [Member]      
Segment Reporting Information [Line Items]      
Revenue 290,814 300,870 305,654
Asia and Pacific Area Countries [Member]      
Segment Reporting Information [Line Items]      
Revenue $ 244,970 $ 271,401 $ 247,896
v3.24.0.1
Restructuring charges - Restructuring Costs (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Costs
11. Restructuring charges
Restructuring charges for each period were as follows:
Year ended December 31,
(in thousands)
202320222021
Cost of revenue
$(90)$8,090 $70 
Research and development
687 244 600 
Sales and marketing
130 137 361 
General and administrative
11 77 195 
Total restructuring charges
$738 $8,548 $1,226 
    
Restructuring charges $ 738 $ 8,548 $ 1,226
Cost of Revenue [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges (90) 8,090 70
Research and Development [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 687 244 600
Selling and Marketing Expense [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 130 137 361
General and Administrative [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 11 77 $ 195
fourth quarter 2022 restructuring      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges (184)    
Restructuring Reserve 0 7,833  
Other Restructuring Costs (184)    
Cash paid (7,649)    
Restructuring charges 8,100    
fourth quarter 2022 restructuring | Other Restructuring [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve 0 $ 7,833  
Cash paid $ (7,649)    
v3.24.0.1
Restructuring charges - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 738 $ 8,548 $ 1,226
fourth quarter 2022 restructuring      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 8,100    
Other Restructuring Costs (184)    
fourth quarter 2022 restructuring contract costs [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 7,000    
fourth quarter 2022 restructuring transition costs [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 1,100    
v3.24.0.1
Subsequent Events (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Subsequent Event [Line Items]      
Restructuring charges $ 738 $ 8,548 $ 1,226
Sublease Income $ 2,281 $ 2,907 $ 964
Operating Lease, Weighted Average Discount Rate, Percent 6.20% 6.10%  
v3.24.0.1
Valuation and Qualifying Accounts (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Allowance for Doubtful Accounts Receivable [Member]        
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]        
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $ 450,000 $ 390,000 $ 700,000 $ 492,000
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]        
Charges to Expense 67,000 (294,000) 393,000  
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction (7,000) (16,000) (185,000)  
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $ 450,000 $ 390,000 700,000  
SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]        
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]        
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount     0 $ 287,276,000
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]        
Charges to Expense     (284,551,000)  
Charges to Revenue     0  
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction     (2,725,000)  
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount     $ 0  
v3.24.0.1
Label Element Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $ 327,654,000